data_2os6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2os6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.431 ' HB ' ' HG ' ' A' ' 80' ' ' LEU . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' CD2' HD11 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG22 ' CG1' ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.494 ' CG2' HG23 ' A' ' 60' ' ' VAL . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 30' ' ' VAL . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 69' ' ' VAL . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 68' ' ' VAL . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' ' HB ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.873 0.368 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.577 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' THR . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 8.9 m120 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.507 ' HB ' HG22 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG22 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD11 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' ASN . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' ARG . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.588 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.607 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 HD22 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.411 HD22 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.94 0.4 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m120 -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.885 0.374 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' CG1' HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m120 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.406 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 20' ' ' PHE . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CD2' HG21 ' A' ' 13' ' ' ILE . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.551 ' CG1' HG13 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.57 ' HB ' HG22 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.57 HG22 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 69' ' ' VAL . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.42 ' N ' HG12 ' A' ' 68' ' ' VAL . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.517 ' CG1' HG13 ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.603 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.6 m120 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.664 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG2' HD13 ' A' ' 52' ' ' ILE . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 69' ' ' VAL . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 68' ' ' VAL . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.687 0.279 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.401 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.418 HG21 HG12 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 HG21 ' A' ' 72' ' ' ILE . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.527 0.203 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.625 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HA ' HG13 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 66' ' ' LEU . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.054 0.454 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG22 ' A' ' 46' ' ' VAL . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.655 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 13' ' ' ILE . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 68' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG21 HG13 ' A' ' 60' ' ' VAL . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.45 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.497 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 ' CG1' ' A' ' 60' ' ' VAL . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HD12 ' A' ' 53' ' ' ILE . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.409 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE2' HG21 ' A' ' 72' ' ' ILE . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HB ' HG21 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 8' ' ' GLN . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HG21 ' CE2' ' A' ' 20' ' ' PHE . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.735 0.302 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.706 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.581 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.746 0.307 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 30' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.572 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.406 HG23 ' CZ ' ' A' ' 20' ' ' PHE . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.622 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 68' ' ' VAL . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 60' ' ' VAL . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG2' HD23 ' A' ' 80' ' ' LEU . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD23 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 72' ' ' ILE . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.461 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 29' ' ' PRO . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 60' ' ' VAL . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG13 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 30' ' ' VAL . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.461 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 12.8 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.628 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG12 HD22 ' A' ' 71' ' ' LEU . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 HG12 ' A' ' 55' ' ' VAL . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.688 0.28 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 13' ' ' ILE . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.488 ' HB ' HG22 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.443 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.473 ' HB ' HG21 ' B' ' 95' ' ' THR . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.2 p -97.38 162.22 13.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.661 0.267 . . . . 0.0 111.476 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 67.41 94.56 0.07 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -113.73 154.68 26.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.384 . . . . 0.0 111.355 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.11 -66.46 0.57 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -145.05 112.35 6.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.78 148.17 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.32 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.431 ' HB ' ' HG ' ' A' ' 80' ' ' LEU . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' CD2' HD11 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG22 ' CG1' ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.494 ' CG2' HG23 ' A' ' 60' ' ' VAL . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 30' ' ' VAL . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 69' ' ' VAL . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 68' ' ' VAL . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' ' HB ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.02 -154.22 6.08 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.29 148.8 35.88 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.403 0.144 . . . . 0.0 110.619 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 110.64 2.92 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.612 2.208 . . . . 0.0 112.294 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.27 108.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.581 2.188 . . . . 0.0 112.176 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.57 66.62 1.7 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.227 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.069 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.403 0.144 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.05 111.17 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.078 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -113.81 43.33 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.772 0.32 . . . . 0.0 111.706 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.77 42.18 0.79 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -85.25 70.51 10.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.949 0.404 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -141.38 24.7 2.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.99 31.88 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.599 0.238 . . . . 0.0 111.505 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.99 22.34 1.6 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -156.62 74.63 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.837 0.351 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.02 140.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.577 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' THR . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 172.73 42.78 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -120.06 80.06 26.5 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.633 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.78 130.41 37.12 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.747 2.298 . . . . 0.0 112.156 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.15 112.16 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.823 2.348 . . . . 0.0 112.698 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 -91.8 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.12 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 71.66 163.48 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.88 148.66 51.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.6 48.38 2.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -99.21 -36.36 9.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.511 0.195 . . . . 0.0 111.485 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -97.73 126.73 43.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 111.327 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ptm -141.81 136.76 30.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.67 71.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.781 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.79 127.98 12.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.637 0.256 . . . . 0.0 111.196 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.08 133.99 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.411 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 8.9 m120 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.507 ' HB ' HG22 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG22 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD11 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' ASN . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' ARG . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 143.99 6.46 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.19 96.0 49.15 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-O 120.692 0.282 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 113.28 3.37 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.698 2.265 . . . . 0.0 112.117 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.35 128.13 28.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.813 2.342 . . . . 0.0 112.704 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.3 74.67 0.96 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.377 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.926 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.577 0.227 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -113.48 134.78 54.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.789 0.328 . . . . 0.0 111.183 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.07 38.26 1.76 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -131.55 66.18 1.55 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 27.91 4.81 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.259 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -175.33 -61.68 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.606 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.5 mmm 66.25 160.17 0.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.98 -95.67 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.74 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.5 mt -115.79 170.32 8.55 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.853 0.359 . . . . 0.0 111.067 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.82 141.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.027 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.588 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.607 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 HD22 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.17 144.8 4.18 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -124.3 146.21 51.12 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.72 0.295 . . . . 0.0 111.037 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.25 153.72 45.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.688 2.258 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 125.91 11.9 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.717 2.278 . . . . 0.0 112.382 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.79 -132.41 1.77 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.7 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.794 0.33 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.58 117.18 27.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -121.29 166.92 13.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.968 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.09 102.81 11.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.411 HD22 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 m -110.74 136.54 49.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.16 -178.99 3.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.3 mtt 66.28 -177.58 0.19 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.68 103.05 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.282 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.07 147.47 42.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m -107.79 143.52 18.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.408 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m120 -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.03 -156.01 8.22 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -61.45 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.131 0.173 . . . . 0.0 111.198 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 111.16 1.43 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.568 2.178 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 113.05 3.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.819 2.346 . . . . 0.0 112.512 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.72 52.01 0.73 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.835 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.215 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.461 0.172 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -89.2 -60.47 1.94 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.791 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.23 178.46 8.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 50.28 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.29 -75.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.422 0.289 . . . . 0.0 111.341 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.42 174.09 0.14 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.255 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 177.77 0.14 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 111.222 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.08 -110.3 0.36 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.149 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.15 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.06 138.94 42.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.393 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.444 ' CG1' HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m120 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.406 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.53 168.25 25.0 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -165.67 129.39 1.66 Allowed Pre-proline 0 C--O 1.233 0.233 0 C-N-CA 122.04 0.136 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.51 110.04 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.836 2.357 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.66 170.53 16.24 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.805 2.337 . . . . 0.0 112.679 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.46 71.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.622 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.082 -179.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.19 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.94 -161.8 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -54.36 161.14 1.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 111.349 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 132.57 49.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.373 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -85.0 165.49 17.52 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.726 0.298 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 156.16 43.08 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.304 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.73 159.2 16.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.463 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.77 44.65 0.02 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.925 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 59.76 -179.87 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.03 118.31 46.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 20' ' ' PHE . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CD2' HG21 ' A' ' 13' ' ' ILE . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.551 ' CG1' HG13 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.57 ' HB ' HG22 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.57 HG22 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 69' ' ' VAL . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.42 ' N ' HG12 ' A' ' 68' ' ' VAL . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.65 24.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -101.77 152.54 38.13 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.553 0.216 . . . . 0.0 110.84 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.88 111.67 2.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.69 2.26 . . . . 0.0 112.083 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.2 97.41 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.42 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.79 -67.44 3.66 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.353 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.095 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.68 86.59 0.11 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-O 121.086 0.47 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.84 -178.4 6.25 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -146.01 48.48 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.86 29.81 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -173.32 123.84 0.39 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.3 39.74 3.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.61 27.86 56.26 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.966 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -154.33 141.09 19.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.738 0.269 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.38 144.58 37.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.517 ' CG1' HG13 ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.603 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.6 m120 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.664 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG2' HD13 ' A' ' 52' ' ' ILE . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 69' ' ' VAL . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 68' ' ' VAL . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.71 -149.88 8.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 80.25 20.59 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.73 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.37 152.72 66.3 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.642 2.228 . . . . 0.0 112.324 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.85 149.74 66.73 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.536 2.157 . . . . 0.0 112.582 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 34.38 30.64 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.773 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.264 179.845 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.601 0.239 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.39 168.5 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 67.82 169.82 0.27 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.61 66.85 0.84 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.61 42.58 1.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.08 169.76 15.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.8 105.0 4.17 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.189 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 6' ' ' LEU . . . -110.78 -39.7 1.4 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.807 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 5.5 mt 66.59 156.85 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.12 122.06 57.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.518 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.401 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.418 HG21 HG12 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 HG21 ' A' ' 72' ' ' ILE . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.21 6.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -140.81 123.54 9.78 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.566 0.183 . . . . 0.0 110.669 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.44 166.94 3.04 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.78 2.32 . . . . 0.0 112.281 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 127.82 19.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.348 2.032 . . . . 0.0 111.751 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.36 -96.89 0.02 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.045 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.727 0.299 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -150.64 123.53 8.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -124.29 146.91 48.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -112.11 83.03 1.73 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 CA-C-O 120.21 -0.217 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -118.51 12.86 13.35 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.92 0.36 . . . . 0.0 111.509 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.49 23.27 7.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mmt -155.52 179.2 9.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.826 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.63 73.83 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.598 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.89 101.46 7.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.017 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.25 149.07 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.625 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HA ' HG13 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 66' ' ' LEU . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 147.08 135.43 2.69 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.04 125.2 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 122.666 0.387 . . . . 0.0 111.407 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 112.05 2.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.558 2.172 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.76 112.24 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.797 2.332 . . . . 0.0 112.424 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.42 -61.65 0.63 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.746 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.05 35.15 3.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -104.64 99.78 9.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.649 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 47.35 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 112.845 -0.102 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -92.29 157.16 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.333 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.18 106.2 4.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.0 tpt -116.35 151.87 35.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.47 47.97 1.06 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.982 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 61.37 105.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p -108.95 128.83 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG22 ' A' ' 46' ' ' VAL . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.655 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 13' ' ' ILE . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 68' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG21 HG13 ' A' ' 60' ' ' VAL . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.45 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.34 162.4 24.82 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -144.06 99.55 5.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-O 120.679 0.276 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.446 ' HB2' ' HD3' ' A' ' 87' ' ' PRO . 51.5 Cg_exo -53.43 -45.84 38.17 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.839 2.36 . . . . 0.0 112.975 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 86' ' ' PRO . 31.8 Cg_exo -58.77 124.79 16.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.371 2.047 . . . . 0.0 112.632 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.78 -79.29 0.26 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.116 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.574 -179.395 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.53 154.08 51.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.674 0.273 . . . . 0.0 111.083 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 66.33 107.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.426 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -128.41 56.2 1.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.975 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.909 -0.077 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -109.7 176.51 5.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -147.47 -66.49 0.26 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mpp? 67.44 153.66 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.75 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.39 44.15 2.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.327 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.64 172.88 8.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 86' ' ' PRO . 34.4 m -128.03 135.39 62.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.853 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.497 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 ' CG1' ' A' ' 60' ' ' VAL . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.77 -145.01 4.04 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.79 158.02 37.18 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.576 0.227 . . . . 0.0 110.712 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' HG21 ' A' ' 7' ' ' VAL . 22.2 Cg_endo -60.57 128.92 27.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.09 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.84 104.89 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.873 2.382 . . . . 0.0 112.54 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.74 -103.48 0.81 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.709 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.005 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -120.22 174.55 6.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -166.81 137.82 3.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.299 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -144.53 68.77 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.925 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 120.393 -0.115 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.58 132.85 53.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.12 40.24 22.14 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.468 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtp -93.26 154.72 17.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.28 -125.93 2.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.788 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.409 ' HB2' ' NE2' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -156.62 151.57 26.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.5 136.0 60.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.268 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HG3' HD12 ' A' ' 53' ' ' ILE . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.409 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE2' HG21 ' A' ' 72' ' ' ILE . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HB ' HG21 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 8' ' ' GLN . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HG21 ' CE2' ' A' ' 20' ' ' PHE . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 6' ' ' LEU . 2.1 tm0? -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.78 177.54 28.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.9 mtt180 -97.99 109.62 52.31 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.87 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.858 2.372 . . . . 0.0 112.457 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.42 77.33 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.075 2.516 . . . . 0.0 112.366 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.11 75.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.113 -179.691 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.517 0.199 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 57.78 72.04 0.54 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.301 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -157.94 -52.21 0.07 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.769 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -126.98 72.97 1.38 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.37 -75.56 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.622 0.211 . . . . 0.0 110.793 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.46 125.1 28.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.904 0.383 . . . . 0.0 111.343 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 91.73 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 -115.17 0.38 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.768 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.79 171.09 7.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.672 0.273 . . . . 0.0 110.947 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.57 122.95 62.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.706 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.581 HG21 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.86 177.7 23.17 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -171.57 155.2 3.97 Favored Pre-proline 0 N--CA 1.463 0.222 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.34 109.76 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.36 151.38 71.35 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.548 2.165 . . . . 0.0 112.44 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.65 44.04 27.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.208 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.263 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.81 34.76 25.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.68 177.55 4.6 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -165.65 94.54 0.6 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -150.99 167.97 26.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.399 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -160.93 41.19 0.16 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.48 178.75 9.57 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.71 99.94 0.15 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.689 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.33 163.86 15.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 111.091 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.5 135.79 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 30' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.572 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.406 HG23 ' CZ ' ' A' ' 20' ' ' PHE . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.44 -142.26 7.06 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -100.36 158.0 32.76 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.559 0.219 . . . . 0.0 110.763 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.8 Cg_exo -56.68 139.07 87.45 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.638 2.225 . . . . 0.0 112.219 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 35.3 Cg_exo -62.25 -172.17 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.044 2.496 . . . . 0.0 112.791 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.64 -67.12 0.68 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.773 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.162 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.58 128.08 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.61 108.45 21.15 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.053 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.84 41.53 3.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.28 134.48 38.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.991 0.424 . . . . 0.0 111.39 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -73.08 168.83 18.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.324 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.22 146.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.315 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.16 -77.29 2.14 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.839 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.55 157.16 37.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.8 125.1 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.622 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 68' ' ' VAL . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 60' ' ' VAL . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG2' HD23 ' A' ' 80' ' ' LEU . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD23 ' CG2' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.38 -155.26 7.42 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -141.23 103.78 6.08 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 152.39 77.81 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.79 137.39 67.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.751 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.36 40.45 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.382 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.0 159.61 25.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -101.74 173.98 6.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.61 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.12 77.84 1.81 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.148 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 120.264 -0.186 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t 56.92 78.19 0.23 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.983 0.42 . . . . 0.0 110.996 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 56.48 76.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.393 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.06 167.21 30.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.358 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.79 106.79 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.745 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.93 148.63 48.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.513 0.197 . . . . 0.0 111.122 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.38 126.01 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 72' ' ' ILE . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -170.05 -151.49 7.44 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 75.91 79.41 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 110.541 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.57 110.68 2.57 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.898 2.398 . . . . 0.0 112.548 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.23 162.59 41.76 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.758 2.306 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.3 95.2 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.648 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.925 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.189 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.07 31.38 4.44 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.062 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -126.23 128.81 47.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.855 0.36 . . . . 0.0 111.004 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 45.17 0.84 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 56.65 74.55 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.938 0.399 . . . . 0.0 111.372 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -133.8 121.81 22.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -109.25 33.38 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.16 -82.18 0.23 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.869 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.21 178.92 4.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.64 0.257 . . . . 0.0 110.991 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.09 139.32 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.249 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.461 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 29' ' ' PRO . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 60' ' ' VAL . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG13 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 30' ' ' VAL . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.461 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 12.8 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.72 141.55 5.9 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -144.99 99.63 4.64 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.661 0.267 . . . . 0.0 111.095 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.59 159.79 22.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.774 2.316 . . . . 0.0 112.274 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.86 -177.13 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.054 2.503 . . . . 0.0 112.918 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.64 -43.54 0.35 Allowed Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.604 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.678 0.275 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -59.64 2.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -78.47 176.08 9.72 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.16 99.18 8.74 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.168 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 108.15 18.42 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.714 0.293 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 175.25 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 59.93 37.83 21.31 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.95 68.48 3.49 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.374 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.35 125.74 53.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.149 0.18 . . . . 0.0 110.669 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.3 134.78 65.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.628 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG12 HD22 ' A' ' 71' ' ' LEU . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 HG12 ' A' ' 55' ' ' VAL . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.12 -143.49 3.87 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.65 101.14 3.73 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.78 170.1 14.74 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.98 132.16 38.2 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.601 2.201 . . . . 0.0 112.484 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.72 -38.79 30.88 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.667 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.535 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.446 0.165 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.8 87.68 7.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.96 135.71 54.46 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 79.82 1.34 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.686 -0.165 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -73.15 -177.47 2.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -175.29 0.85 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.012 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.3 mtm -103.06 107.12 17.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.848 0.356 . . . . 0.0 111.572 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.51 -32.13 3.51 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.766 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.14 178.95 5.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.768 0.284 . . . . 0.0 111.053 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.98 123.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.967 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 13' ' ' ILE . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.488 ' HB ' HG22 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.443 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.473 ' HB ' HG21 ' B' ' 95' ' ' THR . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.57 -167.54 17.98 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 145.69 31.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.474 ' HB2' ' HD3' ' A' ' 87' ' ' PRO . 51.3 Cg_exo -51.59 -49.45 17.15 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.918 2.412 . . . . 0.0 113.12 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 86' ' ' PRO . 72.4 Cg_endo -75.1 135.2 18.58 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -172.02 101.7 0.17 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.462 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.845 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.688 0.28 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.04 154.3 19.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.4 160.57 32.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.25 60.5 1.7 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.434 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB1' ' A' ' 79' ' ' ALA . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.795 HG11 HG22 ' A' ' 46' ' ' VAL . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.435 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.985 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 24' ' ' VAL . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 46' ' ' VAL . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.795 HG22 HG11 ' A' ' 11' ' ' VAL . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 52' ' ' ILE . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 53' ' ' ILE . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 28' ' ' ASN . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.592 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 HD11 ' A' ' 72' ' ' ILE . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.724 HG22 HG21 ' B' ' 95' ' ' THR . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 78' ' ' VAL . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HD2' HG12 ' A' ' 69' ' ' VAL . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG21 HG23 ' A' ' 72' ' ' ILE . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD12 ' CG1' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.797 ' CG1' HD12 ' A' ' 80' ' ' LEU . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.724 HG21 HG22 ' A' ' 69' ' ' VAL . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.525 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.873 0.368 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 81' ' ' THR . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.762 HG21 HG22 ' A' ' 46' ' ' VAL . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.52 ' HD2' HD22 ' B' ' 97' ' ' LEU . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 31' ' ' PHE . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 52' ' ' ILE . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 11' ' ' VAL . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.79 HD12 HG11 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG21 HG13 ' A' ' 68' ' ' VAL . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' CG2' ' A' ' 30' ' ' VAL . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG13 HG21 ' A' ' 55' ' ' VAL . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 78' ' ' VAL . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 72' ' ' ILE . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.624 HD22 ' HB ' ' A' ' 55' ' ' VAL . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.493 HG23 ' SG ' ' A' ' 10' ' ' CYS . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG22 ' A' ' 82' ' ' VAL . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 20' ' ' PHE . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 46' ' ' VAL . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.472 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 46' ' ' VAL . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CB ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 30' ' ' VAL . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 32.7 m-80 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 48' ' ' THR . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' LEU . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 11' ' ' VAL . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 34' ' ' SER . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.756 HD11 ' CD ' ' A' ' 83' ' ' GLN . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG22 HD23 ' A' ' 80' ' ' LEU . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG23 ' A' ' 30' ' ' VAL . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HD12 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.626 ' O ' HG23 ' A' ' 68' ' ' VAL . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.519 ' HB ' HG21 ' B' ' 95' ' ' THR . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.667 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 55' ' ' VAL . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.756 ' CD ' HD11 ' A' ' 53' ' ' ILE . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.519 HG21 ' HB ' ' A' ' 69' ' ' VAL . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.799 HD11 ' HE2' ' A' ' 73' ' ' LYS . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.057 ' HB ' HG23 ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 51' ' ' ARG . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' HG23 ' A' ' 24' ' ' VAL . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 46' ' ' VAL . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.057 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.742 ' HB ' HD11 ' A' ' 72' ' ' ILE . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 30' ' ' VAL . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.458 ' OG1' HD22 ' A' ' 59' ' ' LEU . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG23 HD21 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.693 ' HE2' HD11 ' B' ' 97' ' ' LEU . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 80' ' ' LEU . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 78' ' ' VAL . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.54 ' O ' HD22 ' B' ' 97' ' ' LEU . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.693 HD21 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.94 0.4 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 46' ' ' VAL . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.965 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 36' ' ' LYS . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.435 HG23 ' HB3' ' B' ' 96' ' ' ASP . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.856 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.601 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.049 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.856 ' HA ' HG12 ' A' ' 24' ' ' VAL . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.709 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 11' ' ' VAL . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.049 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' HG ' ' A' ' 80' ' ' LEU . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.718 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 28' ' ' ASN . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.718 ' OG1' HD22 ' A' ' 59' ' ' LEU . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.548 HG12 ' HE3' ' A' ' 73' ' ' LYS . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.588 HG23 HG21 ' A' ' 78' ' ' VAL . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.746 ' HE2' HD21 ' B' ' 97' ' ' LEU . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 72' ' ' ILE . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.652 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.965 HD13 HD12 ' A' ' 13' ' ' ILE . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 69' ' ' VAL . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 23' ' ' THR . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.746 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.885 0.374 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 20' ' ' PHE . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 13' ' ' ILE . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE ' ' A' ' 36' ' ' LYS . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 35' ' ' VAL . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 34' ' ' SER . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG12 HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 2.5 m-80 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.946 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 23' ' ' THR . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 22' ' ' LEU . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 35' ' ' VAL . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 34' ' ' SER . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.946 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 78' ' ' VAL . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 55' ' ' VAL . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.565 ' OG1' HD12 ' A' ' 59' ' ' LEU . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 68' ' ' VAL . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' NZ ' HD21 ' B' ' 97' ' ' LEU . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.865 HG23 HD11 ' A' ' 80' ' ' LEU . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.652 HG12 ' CB ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 53' ' ' ILE . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.454 HD21 ' NZ ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 HG13 HD13 ' A' ' 80' ' ' LEU . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' CG ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.026 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 22' ' ' LEU . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG12 HG11 ' A' ' 35' ' ' VAL . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 48' ' ' THR . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.026 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD12 ' OG1' ' A' ' 61' ' ' THR . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 59' ' ' LEU . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.464 ' O ' HG12 ' A' ' 68' ' ' VAL . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 68' ' ' VAL . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.629 HG13 HD11 ' A' ' 80' ' ' LEU . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 69' ' ' VAL . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.61 ' CG ' HG23 ' A' ' 23' ' ' THR . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 ' CG1' ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.619 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m-80 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.969 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 48' ' ' THR . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.969 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 60' ' ' VAL . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 80' ' ' LEU . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.64 ' O ' HG12 ' A' ' 68' ' ' VAL . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 65' ' ' HIS . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.858 HG12 ' HE3' ' A' ' 73' ' ' LYS . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.858 ' HE3' HG12 ' A' ' 69' ' ' VAL . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HD11 ' A' ' 80' ' ' LEU . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 78' ' ' VAL . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.687 0.279 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 46' ' ' VAL . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 22' ' ' LEU . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.675 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 48' ' ' THR . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 13' ' ' ILE . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 34' ' ' SER . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 60' ' ' VAL . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 80' ' ' LEU . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.712 ' CG ' HG23 ' A' ' 78' ' ' VAL . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 28' ' ' ASN . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 66' ' ' LEU . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 64' ' ' ASN . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.53 HG22 HG21 ' B' ' 95' ' ' THR . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 69' ' ' VAL . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.712 HG23 ' CG ' ' A' ' 56' ' ' ASN . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 53' ' ' ILE . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.53 HG21 HG22 ' A' ' 69' ' ' VAL . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.527 0.203 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.612 ' OE1' HD12 ' A' ' 53' ' ' ILE . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.555 HG21 HG22 ' A' ' 46' ' ' VAL . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.017 HD21 HG13 ' A' ' 24' ' ' VAL . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.017 HG13 HD21 ' A' ' 22' ' ' LEU . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 24' ' ' VAL . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 48' ' ' THR . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 22' ' ' LEU . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 11' ' ' VAL . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 33' ' ' GLN . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 60' ' ' VAL . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.871 ' O ' HG22 ' A' ' 58' ' ' THR . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 55' ' ' VAL . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 53' ' ' ILE . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 78' ' ' VAL . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG23 ' A' ' 72' ' ' ILE . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 55' ' ' VAL . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.054 0.454 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.667 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 44' ' ' ALA . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.764 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.668 HG23 ' CB ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 32' ' ' VAL . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.65 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.054 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 24' ' ' VAL . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.663 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG12 HG11 ' A' ' 35' ' ' VAL . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.734 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.054 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' HG ' ' A' ' 80' ' ' LEU . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.739 HG21 HD13 ' A' ' 71' ' ' LEU . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 60' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 66' ' ' LEU . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 58' ' ' THR . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 HG12 ' A' ' 68' ' ' VAL . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 72' ' ' ILE . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 52' ' ' ILE . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 24' ' ' VAL . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.668 ' CB ' HG23 ' A' ' 23' ' ' THR . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 46' ' ' VAL . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 80' ' ' LEU . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 32' ' ' VAL . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.611 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.024 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 24' ' ' VAL . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 46' ' ' VAL . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG22 HG21 ' A' ' 11' ' ' VAL . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' GLN . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.024 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' HD12 ' A' ' 59' ' ' LEU . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 69' ' ' VAL . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.478 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 80' ' ' LEU . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 82' ' ' VAL . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.428 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.931 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD22 ' B' ' 97' ' ' LEU . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD23 ' CB ' ' A' ' 41' ' ' ALA . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HB3' ' B' ' 96' ' ' ASP . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG13 ' B' ' 94' ' ' VAL . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB3' HG22 ' B' ' 94' ' ' VAL . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.565 HG13 ' HB1' ' A' ' 41' ' ' ALA . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' CB ' HD23 ' A' ' 22' ' ' LEU . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 35' ' ' VAL . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.671 ' O ' HG12 ' A' ' 60' ' ' VAL . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 68' ' ' VAL . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.578 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' OD1' ' A' ' 28' ' ' ASN . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 55' ' ' VAL . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.583 HG22 ' HE3' ' A' ' 73' ' ' LYS . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 55' ' ' VAL . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HE3' HG22 ' A' ' 69' ' ' VAL . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 80' ' ' LEU . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' ILE . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 24' ' ' VAL . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.751 ' HB3' HG23 ' A' ' 23' ' ' THR . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 20' ' ' PHE . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.735 0.302 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG22 ' A' ' 46' ' ' VAL . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.683 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 95' ' ' THR . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.688 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.064 ' HB ' HG23 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.835 HG22 HG11 ' A' ' 11' ' ' VAL . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 35' ' ' VAL . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.064 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.94 HG21 HG13 ' A' ' 68' ' ' VAL . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.466 HG23 HD22 ' A' ' 28' ' ' ASN . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.67 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.94 HG13 HG21 ' A' ' 55' ' ' VAL . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.721 HG22 ' HE3' ' A' ' 73' ' ' LYS . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.683 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' A' ' 69' ' ' VAL . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 72' ' ' ILE . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.746 0.307 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 82' ' ' VAL . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.674 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 32' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.407 ' OG ' HG22 ' B' ' 94' ' ' VAL . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 24' ' ' VAL . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.692 HG22 HG12 ' A' ' 24' ' ' VAL . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.792 HG12 HG23 ' A' ' 48' ' ' THR . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HA ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.792 HG23 HG12 ' A' ' 35' ' ' VAL . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.609 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HE2' HD23 ' A' ' 59' ' ' LEU . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 80' ' ' LEU . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 HG12 ' A' ' 78' ' ' VAL . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HE2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 53' ' ' ILE . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG12 HD11 ' A' ' 72' ' ' ILE . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.569 HG22 HG21 ' B' ' 95' ' ' THR . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 HG12 ' A' ' 68' ' ' VAL . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' NZ ' HD11 ' B' ' 97' ' ' LEU . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 72' ' ' ILE . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.407 HG22 ' OG ' ' A' ' 25' ' ' SER . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.45 HD11 ' NZ ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 22' ' ' LEU . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.788 ' HB2' HD22 ' B' ' 97' ' ' LEU . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.065 ' HB ' HG23 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 48' ' ' THR . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 22' ' ' LEU . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.813 HG22 HG11 ' A' ' 11' ' ' VAL . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 34' ' ' SER . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.065 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 72' ' ' ILE . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 64' ' ' ASN . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 73' ' ' LYS . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 55' ' ' VAL . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 69' ' ' VAL . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 56' ' ' ASN . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.63 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 82' ' ' VAL . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.627 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.628 HD12 HD22 ' A' ' 80' ' ' LEU . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.56 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' A' ' 35' ' ' VAL . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 32' ' ' VAL . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.6 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 24' ' ' VAL . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 22' ' ' LEU . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG12 HG11 ' A' ' 35' ' ' VAL . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.954 HD11 HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.529 ' O ' HG22 ' A' ' 60' ' ' VAL . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 53' ' ' ILE . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 80' ' ' LEU . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG12 ' ND2' ' A' ' 56' ' ' ASN . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.954 HD23 HD11 ' A' ' 52' ' ' ILE . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.529 ' C ' HD23 ' B' ' 97' ' ' LEU . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.529 HD23 ' C ' ' B' ' 96' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 46' ' ' VAL . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 80' ' ' LEU . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB3' ' B' ' 96' ' ' ASP . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 11' ' ' VAL . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.871 HG12 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.746 HD12 ' OG1' ' A' ' 61' ' ' THR . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.746 ' OG1' HD12 ' A' ' 59' ' ' LEU . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' ASN . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 80' ' ' LEU . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.871 ' HG ' HG12 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 12.8 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.625 ' HB3' HG23 ' A' ' 23' ' ' THR . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.914 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 80' ' ' LEU . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HA ' ' B' ' 96' ' ' ASP . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.653 HG23 HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 22' ' ' LEU . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.914 HG22 HG11 ' A' ' 11' ' ' VAL . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 34' ' ' SER . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG23 HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.653 ' HE3' HG21 ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 52' ' ' ILE . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 78' ' ' VAL . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 60' ' ' VAL . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 HG21 ' B' ' 95' ' ' THR . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 71' ' ' LEU . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' CD1' HG12 ' A' ' 68' ' ' VAL . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 80' ' ' LEU . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 78' ' ' VAL . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.653 HG21 ' HE3' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.505 HG21 HG22 ' A' ' 69' ' ' VAL . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.688 0.28 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 81' ' ' THR . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.87 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.994 ' HB ' HG23 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 48' ' ' THR . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.87 HG22 HG21 ' A' ' 11' ' ' VAL . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' SER . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CD ' HG21 ' A' ' 81' ' ' THR . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 ' HG ' ' A' ' 80' ' ' LEU . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 28' ' ' ASN . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 71' ' ' LEU . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 72' ' ' ILE . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 73' ' ' LYS . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.742 HG23 HG11 ' A' ' 78' ' ' VAL . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 69' ' ' VAL . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG11 HG23 ' A' ' 72' ' ' ILE . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.494 HG23 ' SG ' ' A' ' 10' ' ' CYS . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.533 HD21 HG21 ' A' ' 72' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.2 p -97.38 162.22 13.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.661 0.267 . . . . 0.0 111.476 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 67.41 94.56 0.07 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -113.73 154.68 26.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.384 . . . . 0.0 111.355 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.11 -66.46 0.57 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -145.05 112.35 6.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.78 148.17 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.32 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB1' ' A' ' 79' ' ' ALA . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.795 HG11 HG22 ' A' ' 46' ' ' VAL . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.435 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.985 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 24' ' ' VAL . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 46' ' ' VAL . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.795 HG22 HG11 ' A' ' 11' ' ' VAL . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 52' ' ' ILE . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 53' ' ' ILE . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 28' ' ' ASN . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.592 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 HD11 ' A' ' 72' ' ' ILE . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.724 HG22 HG21 ' B' ' 95' ' ' THR . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 78' ' ' VAL . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HD2' HG12 ' A' ' 69' ' ' VAL . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG21 HG23 ' A' ' 72' ' ' ILE . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD12 ' CG1' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.797 ' CG1' HD12 ' A' ' 80' ' ' LEU . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.02 -154.22 6.08 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.29 148.8 35.88 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.403 0.144 . . . . 0.0 110.619 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 57.5 Cg_endo -71.54 110.64 2.92 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.612 2.208 . . . . 0.0 112.294 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 53.5 Cg_endo -70.27 108.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.581 2.188 . . . . 0.0 112.176 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.57 66.62 1.7 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.227 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.069 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.403 0.144 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.05 111.17 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.078 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -113.81 43.33 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.772 0.32 . . . . 0.0 111.706 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.77 42.18 0.79 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.724 HG21 HG22 ' A' ' 69' ' ' VAL . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.525 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -85.25 70.51 10.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.949 0.404 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -141.38 24.7 2.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.99 31.88 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.599 0.238 . . . . 0.0 111.505 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.99 22.34 1.6 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 6' ' ' LEU . 15.4 mt -156.62 74.63 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.837 0.351 . . . . 0.0 110.288 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.02 140.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 81' ' ' THR . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.762 HG21 HG22 ' A' ' 46' ' ' VAL . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.52 ' HD2' HD22 ' B' ' 97' ' ' LEU . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 31' ' ' PHE . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 52' ' ' ILE . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 11' ' ' VAL . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.79 HD12 HG11 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG21 HG13 ' A' ' 68' ' ' VAL . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' CG2' ' A' ' 30' ' ' VAL . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG13 HG21 ' A' ' 55' ' ' VAL . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 78' ' ' VAL . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 72' ' ' ILE . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.624 HD22 ' HB ' ' A' ' 55' ' ' VAL . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.493 HG23 ' SG ' ' A' ' 10' ' ' CYS . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG22 ' A' ' 82' ' ' VAL . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 172.73 42.78 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -120.06 80.06 26.5 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.633 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.78 130.41 37.12 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.747 2.298 . . . . 0.0 112.156 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.15 112.16 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.823 2.348 . . . . 0.0 112.698 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 -91.8 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.12 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 71.66 163.48 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.88 148.66 51.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.6 48.38 2.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 20' ' ' PHE . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -99.21 -36.36 9.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.511 0.195 . . . . 0.0 111.485 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -97.73 126.73 43.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 111.327 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ptm -141.81 136.76 30.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.67 71.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.781 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.79 127.98 12.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.637 0.256 . . . . 0.0 111.196 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.08 133.99 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.411 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 46' ' ' VAL . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.472 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 46' ' ' VAL . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CB ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 30' ' ' VAL . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 32.7 m-80 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 48' ' ' THR . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' LEU . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 11' ' ' VAL . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 34' ' ' SER . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.756 HD11 ' CD ' ' A' ' 83' ' ' GLN . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG22 HD23 ' A' ' 80' ' ' LEU . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG23 ' A' ' 30' ' ' VAL . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HD12 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.626 ' O ' HG23 ' A' ' 68' ' ' VAL . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.519 ' HB ' HG21 ' B' ' 95' ' ' THR . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.667 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 55' ' ' VAL . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.756 ' CD ' HD11 ' A' ' 53' ' ' ILE . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 143.99 6.46 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.19 96.0 49.15 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-O 120.692 0.282 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 113.28 3.37 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.698 2.265 . . . . 0.0 112.117 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.35 128.13 28.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.813 2.342 . . . . 0.0 112.704 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.3 74.67 0.96 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.377 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.926 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.577 0.227 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -113.48 134.78 54.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.789 0.328 . . . . 0.0 111.183 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.07 38.26 1.76 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -131.55 66.18 1.55 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.519 HG21 ' HB ' ' A' ' 69' ' ' VAL . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.799 HD11 ' HE2' ' A' ' 73' ' ' LYS . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 27.91 4.81 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.259 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -175.33 -61.68 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.606 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.5 mmm 66.25 160.17 0.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.98 -95.67 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.74 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 85' ' ' ARG . 64.5 mt -115.79 170.32 8.55 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.853 0.359 . . . . 0.0 111.067 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.82 141.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.027 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.057 ' HB ' HG23 ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 51' ' ' ARG . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' HG23 ' A' ' 24' ' ' VAL . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 46' ' ' VAL . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.057 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.742 ' HB ' HD11 ' A' ' 72' ' ' ILE . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 30' ' ' VAL . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.458 ' OG1' HD22 ' A' ' 59' ' ' LEU . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG23 HD21 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.693 ' HE2' HD11 ' B' ' 97' ' ' LEU . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 80' ' ' LEU . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 78' ' ' VAL . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.17 144.8 4.18 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HB2' HD22 ' A' ' 6' ' ' LEU . 41.1 mtp85 -124.3 146.21 51.12 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.72 0.295 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.25 153.72 45.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.688 2.258 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 125.91 11.9 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.717 2.278 . . . . 0.0 112.382 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.79 -132.41 1.77 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.7 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.794 0.33 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.58 117.18 27.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -121.29 166.92 13.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.968 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.09 102.81 11.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.54 ' O ' HD22 ' B' ' 97' ' ' LEU . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.693 HD21 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 m -110.74 136.54 49.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.16 -178.99 3.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.3 mtt 66.28 -177.58 0.19 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.68 103.05 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.282 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.1 mp -74.07 147.47 42.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.837 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m -107.79 143.52 18.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.408 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 46' ' ' VAL . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.965 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 36' ' ' LYS . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.435 HG23 ' HB3' ' B' ' 96' ' ' ASP . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.856 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.601 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.049 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.856 ' HA ' HG12 ' A' ' 24' ' ' VAL . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.709 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 11' ' ' VAL . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.049 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' HG ' ' A' ' 80' ' ' LEU . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.718 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 28' ' ' ASN . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.718 ' OG1' HD22 ' A' ' 59' ' ' LEU . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.548 HG12 ' HE3' ' A' ' 73' ' ' LYS . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.588 HG23 HG21 ' A' ' 78' ' ' VAL . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.746 ' HE2' HD21 ' B' ' 97' ' ' LEU . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 72' ' ' ILE . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.652 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.965 HD13 HD12 ' A' ' 13' ' ' ILE . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.03 -156.01 8.22 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -61.45 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.131 0.173 . . . . 0.0 111.198 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 111.16 1.43 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.568 2.178 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 113.05 3.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.819 2.346 . . . . 0.0 112.512 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.72 52.01 0.73 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.835 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.215 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.461 0.172 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -89.2 -60.47 1.94 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.791 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.23 178.46 8.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 50.28 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 69' ' ' VAL . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 23' ' ' THR . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.746 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.29 -75.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.422 0.289 . . . . 0.0 111.341 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.42 174.09 0.14 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.255 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 177.77 0.14 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 111.222 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.08 -110.3 0.36 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.149 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD23 ' HG2' ' A' ' 83' ' ' GLN . 0.1 OUTLIER 63.15 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.06 138.94 42.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.393 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 20' ' ' PHE . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 13' ' ' ILE . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE ' ' A' ' 36' ' ' LYS . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 35' ' ' VAL . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 34' ' ' SER . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG12 HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 2.5 m-80 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.946 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 23' ' ' THR . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 22' ' ' LEU . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 35' ' ' VAL . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 34' ' ' SER . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.946 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 78' ' ' VAL . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 55' ' ' VAL . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.565 ' OG1' HD12 ' A' ' 59' ' ' LEU . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 68' ' ' VAL . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' NZ ' HD21 ' B' ' 97' ' ' LEU . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.865 HG23 HD11 ' A' ' 80' ' ' LEU . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.652 HG12 ' CB ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HG2' HD23 ' A' ' 6' ' ' LEU . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.53 168.25 25.0 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -165.67 129.39 1.66 Allowed Pre-proline 0 C--O 1.233 0.233 0 C-N-CA 122.04 0.136 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.51 110.04 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.836 2.357 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.66 170.53 16.24 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.805 2.337 . . . . 0.0 112.679 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.46 71.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.622 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.082 -179.519 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.19 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.94 -161.8 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -54.36 161.14 1.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 111.349 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 132.57 49.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.373 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.454 HD21 ' NZ ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -85.0 165.49 17.52 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.726 0.298 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 156.16 43.08 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.304 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.73 159.2 16.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.463 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.77 44.65 0.02 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.925 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 59.76 -179.87 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.03 118.31 46.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 HG13 HD13 ' A' ' 80' ' ' LEU . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' CG ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.026 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 22' ' ' LEU . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG12 HG11 ' A' ' 35' ' ' VAL . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 48' ' ' THR . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.026 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD12 ' OG1' ' A' ' 61' ' ' THR . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 59' ' ' LEU . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' O ' HG12 ' A' ' 68' ' ' VAL . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 68' ' ' VAL . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.629 HG13 HD11 ' A' ' 80' ' ' LEU . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.65 24.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -101.77 152.54 38.13 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.553 0.216 . . . . 0.0 110.84 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.88 111.67 2.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.69 2.26 . . . . 0.0 112.083 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.2 97.41 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.42 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.79 -67.44 3.66 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.353 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.095 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.68 86.59 0.11 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-O 121.086 0.47 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.84 -178.4 6.25 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -146.01 48.48 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 69' ' ' VAL . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.61 ' CG ' HG23 ' A' ' 23' ' ' THR . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.86 29.81 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -173.32 123.84 0.39 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.3 39.74 3.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.61 27.86 56.26 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.966 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD22 ' CD ' ' A' ' 83' ' ' GLN . 2.0 mt -154.33 141.09 19.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.738 0.269 . . . . 0.0 110.715 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.38 144.58 37.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 ' CG1' ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.619 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m-80 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.969 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 48' ' ' THR . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.969 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 60' ' ' VAL . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 80' ' ' LEU . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.64 ' O ' HG12 ' A' ' 68' ' ' VAL . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 65' ' ' HIS . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.858 HG12 ' HE3' ' A' ' 73' ' ' LYS . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.858 ' HE3' HG12 ' A' ' 69' ' ' VAL . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HD11 ' A' ' 80' ' ' LEU . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 78' ' ' VAL . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.419 ' CD ' HD22 ' A' ' 6' ' ' LEU . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.71 -149.88 8.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 80.25 20.59 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.73 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.37 152.72 66.3 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.642 2.228 . . . . 0.0 112.324 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.85 149.74 66.73 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.536 2.157 . . . . 0.0 112.582 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 34.38 30.64 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.773 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.264 179.845 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.601 0.239 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.39 168.5 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 67.82 169.82 0.27 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.61 66.85 0.84 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.61 42.58 1.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.08 169.76 15.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.8 105.0 4.17 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.189 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 6' ' ' LEU . . . -110.78 -39.7 1.4 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.807 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 84' ' ' GLY . 5.5 mt 66.59 156.85 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 86' ' ' PRO . 18.8 t -128.12 122.06 57.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.518 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 46' ' ' VAL . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 22' ' ' LEU . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.675 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 48' ' ' THR . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 13' ' ' ILE . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 34' ' ' SER . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 60' ' ' VAL . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 80' ' ' LEU . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.712 ' CG ' HG23 ' A' ' 78' ' ' VAL . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 28' ' ' ASN . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 66' ' ' LEU . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 64' ' ' ASN . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.53 HG22 HG21 ' B' ' 95' ' ' THR . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 69' ' ' VAL . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.712 HG23 ' CG ' ' A' ' 56' ' ' ASN . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 53' ' ' ILE . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' HD23 ' A' ' 6' ' ' LEU . . . -131.35 -148.21 6.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -140.81 123.54 9.78 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.566 0.183 . . . . 0.0 110.669 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 7' ' ' VAL . 45.4 Cg_exo -56.44 166.94 3.04 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.78 2.32 . . . . 0.0 112.281 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 127.82 19.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.348 2.032 . . . . 0.0 111.751 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.36 -96.89 0.02 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.045 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.552 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 90' ' ' VAL . 16.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.727 0.299 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -150.64 123.53 8.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -124.29 146.91 48.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -112.11 83.03 1.73 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.53 HG21 HG22 ' A' ' 69' ' ' VAL . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 CA-C-O 120.21 -0.217 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -118.51 12.86 13.35 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.92 0.36 . . . . 0.0 111.509 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.49 23.27 7.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mmt -155.52 179.2 9.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.826 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.63 73.83 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.598 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 83' ' ' GLN . 1.0 OUTLIER -119.89 101.46 7.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.017 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.25 149.07 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.612 ' OE1' HD12 ' A' ' 53' ' ' ILE . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.555 HG21 HG22 ' A' ' 46' ' ' VAL . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.017 HD21 HG13 ' A' ' 24' ' ' VAL . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.017 HG13 HD21 ' A' ' 22' ' ' LEU . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 24' ' ' VAL . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 48' ' ' THR . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 22' ' ' LEU . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 11' ' ' VAL . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 33' ' ' GLN . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 60' ' ' VAL . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.871 ' O ' HG22 ' A' ' 58' ' ' THR . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 55' ' ' VAL . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 53' ' ' ILE . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 78' ' ' VAL . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG23 ' A' ' 72' ' ' ILE . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 55' ' ' VAL . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.512 ' OE1' HD12 ' A' ' 6' ' ' LEU . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 147.08 135.43 2.69 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.04 125.2 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 122.666 0.387 . . . . 0.0 111.407 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 112.05 2.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.558 2.172 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.76 112.24 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.797 2.332 . . . . 0.0 112.424 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.42 -61.65 0.63 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.746 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.562 HG22 ' H ' ' B' ' 92' ' ' ASN . 12.3 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.05 35.15 3.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASN . . . . . 0.562 ' H ' HG22 ' B' ' 90' ' ' VAL . 3.0 m120 -104.64 99.78 9.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 47.35 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.667 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 112.845 -0.102 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -92.29 157.16 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.333 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.18 106.2 4.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.0 tpt -116.35 151.87 35.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.47 47.97 1.06 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.982 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.4 mm? 61.37 105.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p -108.95 128.83 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 44' ' ' ALA . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.764 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.668 HG23 ' CB ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 32' ' ' VAL . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.65 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.054 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 24' ' ' VAL . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.663 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG12 HG11 ' A' ' 35' ' ' VAL . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.734 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.054 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' HG ' ' A' ' 80' ' ' LEU . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.739 HG21 HD13 ' A' ' 71' ' ' LEU . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 60' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 66' ' ' LEU . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 58' ' ' THR . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 HG12 ' A' ' 68' ' ' VAL . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 72' ' ' ILE . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 52' ' ' ILE . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.34 162.4 24.82 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -144.06 99.55 5.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-O 120.679 0.276 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 51.5 Cg_exo -53.43 -45.84 38.17 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.839 2.36 . . . . 0.0 112.975 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 31.8 Cg_exo -58.77 124.79 16.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.371 2.047 . . . . 0.0 112.632 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.78 -79.29 0.26 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.116 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.574 -179.395 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.464 HG23 ' H ' ' B' ' 91' ' ' GLU . 3.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.464 ' H ' HG23 ' B' ' 90' ' ' VAL . 0.0 OUTLIER -134.53 154.08 51.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.674 0.273 . . . . 0.0 111.083 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 66.33 107.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.426 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -128.41 56.2 1.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.975 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 24' ' ' VAL . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.668 ' CB ' HG23 ' A' ' 23' ' ' THR . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.909 -0.077 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -109.7 176.51 5.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -147.47 -66.49 0.26 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mpp? 67.44 153.66 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.75 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.39 44.15 2.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.327 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.64 172.88 8.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.683 HG21 ' HD3' ' A' ' 87' ' ' PRO . 34.4 m -128.03 135.39 62.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.853 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 46' ' ' VAL . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 80' ' ' LEU . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 32' ' ' VAL . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.611 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.024 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 24' ' ' VAL . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 46' ' ' VAL . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG22 HG21 ' A' ' 11' ' ' VAL . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' GLN . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.024 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' HD12 ' A' ' 59' ' ' LEU . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 69' ' ' VAL . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.478 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 80' ' ' LEU . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 82' ' ' VAL . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.77 -145.01 4.04 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.79 158.02 37.18 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.576 0.227 . . . . 0.0 110.712 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.57 128.92 27.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.09 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.683 ' HD3' HG21 ' A' ' 7' ' ' VAL . 50.2 Cg_exo -53.84 104.89 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.873 2.382 . . . . 0.0 112.54 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.74 -103.48 0.81 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.709 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.005 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.454 HG23 ' H ' ' B' ' 91' ' ' GLU . 3.6 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.454 ' H ' HG23 ' B' ' 90' ' ' VAL . 4.7 pt-20 -120.22 174.55 6.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -166.81 137.82 3.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.299 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -144.53 68.77 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.925 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.428 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 120.393 -0.115 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.58 132.85 53.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.12 40.24 22.14 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.468 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtp -93.26 154.72 17.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.28 -125.93 2.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.788 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -156.62 151.57 26.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.5 136.0 60.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.268 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.931 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD22 ' B' ' 97' ' ' LEU . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD23 ' CB ' ' A' ' 41' ' ' ALA . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HB3' ' B' ' 96' ' ' ASP . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG13 ' B' ' 94' ' ' VAL . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB3' HG22 ' B' ' 94' ' ' VAL . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG13 ' HB1' ' A' ' 41' ' ' ALA . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' CB ' HD23 ' A' ' 22' ' ' LEU . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 35' ' ' VAL . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.671 ' O ' HG12 ' A' ' 60' ' ' VAL . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 68' ' ' VAL . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.578 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' OD1' ' A' ' 28' ' ' ASN . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 55' ' ' VAL . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.583 HG22 ' HE3' ' A' ' 73' ' ' LYS . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 55' ' ' VAL . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HE3' HG22 ' A' ' 69' ' ' VAL . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 80' ' ' LEU . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' ILE . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.646 ' CG ' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.78 177.54 28.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.9 mtt180 -97.99 109.62 52.31 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.87 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.858 2.372 . . . . 0.0 112.457 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.42 77.33 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.075 2.516 . . . . 0.0 112.366 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.11 75.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.113 -179.691 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.517 0.199 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 57.78 72.04 0.54 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.301 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -157.94 -52.21 0.07 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.769 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -126.98 72.97 1.38 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 24' ' ' VAL . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.751 ' HB3' HG23 ' A' ' 23' ' ' THR . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 20' ' ' PHE . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.37 -75.56 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.622 0.211 . . . . 0.0 110.793 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 125.1 28.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.904 0.383 . . . . 0.0 111.343 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 91.73 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 -115.17 0.38 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.768 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.712 HD21 ' HD3' ' A' ' 85' ' ' ARG . 3.7 mp -105.79 171.09 7.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.672 0.273 . . . . 0.0 110.947 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.57 122.95 62.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG22 ' A' ' 46' ' ' VAL . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.683 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 95' ' ' THR . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.688 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.064 ' HB ' HG23 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.835 HG22 HG11 ' A' ' 11' ' ' VAL . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 35' ' ' VAL . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.064 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.94 HG21 HG13 ' A' ' 68' ' ' VAL . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.466 HG23 HD22 ' A' ' 28' ' ' ASN . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.67 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.94 HG13 HG21 ' A' ' 55' ' ' VAL . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.721 HG22 ' HE3' ' A' ' 73' ' ' LYS . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.683 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' A' ' 69' ' ' VAL . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 72' ' ' ILE . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.86 177.7 23.17 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.712 ' HD3' HD21 ' A' ' 6' ' ' LEU . 26.9 ptt180 -171.57 155.2 3.97 Favored Pre-proline 0 N--CA 1.463 0.222 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 19.4 Cg_endo -58.34 109.76 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 47.3 Cg_endo -69.36 151.38 71.35 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.548 2.165 . . . . 0.0 112.44 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.65 44.04 27.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.208 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.263 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.556 HG23 ' H ' ' B' ' 92' ' ' ASN . 31.3 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.81 34.76 25.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASN . . . . . 0.556 ' H ' HG23 ' B' ' 90' ' ' VAL . 0.8 OUTLIER -114.68 177.55 4.6 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -165.65 94.54 0.6 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -150.99 167.97 26.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.399 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -160.93 41.19 0.16 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.48 178.75 9.57 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.71 99.94 0.15 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.689 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.33 163.86 15.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 111.091 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.5 135.79 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 82' ' ' VAL . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.674 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 32' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.407 ' OG ' HG22 ' B' ' 94' ' ' VAL . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 24' ' ' VAL . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.692 HG22 HG12 ' A' ' 24' ' ' VAL . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.792 HG12 HG23 ' A' ' 48' ' ' THR . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HA ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.792 HG23 HG12 ' A' ' 35' ' ' VAL . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.609 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HE2' HD23 ' A' ' 59' ' ' LEU . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 80' ' ' LEU . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 HG12 ' A' ' 78' ' ' VAL . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HE2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 53' ' ' ILE . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG12 HD11 ' A' ' 72' ' ' ILE . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.569 HG22 HG21 ' B' ' 95' ' ' THR . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 HG12 ' A' ' 68' ' ' VAL . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' NZ ' HD11 ' B' ' 97' ' ' LEU . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 72' ' ' ILE . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.44 -142.26 7.06 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -100.36 158.0 32.76 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.559 0.219 . . . . 0.0 110.763 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.8 Cg_exo -56.68 139.07 87.45 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.638 2.225 . . . . 0.0 112.219 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 35.3 Cg_exo -62.25 -172.17 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.044 2.496 . . . . 0.0 112.791 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.64 -67.12 0.68 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.773 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.162 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.58 128.08 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.61 108.45 21.15 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.053 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.84 41.53 3.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.407 HG22 ' OG ' ' A' ' 25' ' ' SER . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.45 HD11 ' NZ ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.28 134.48 38.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.991 0.424 . . . . 0.0 111.39 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 168.83 18.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.324 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.22 146.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.315 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.16 -77.29 2.14 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.839 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.55 157.16 37.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.8 125.1 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 22' ' ' LEU . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.788 ' HB2' HD22 ' B' ' 97' ' ' LEU . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.065 ' HB ' HG23 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 48' ' ' THR . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 22' ' ' LEU . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.813 HG22 HG11 ' A' ' 11' ' ' VAL . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 34' ' ' SER . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.065 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 72' ' ' ILE . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 64' ' ' ASN . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 73' ' ' LYS . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 55' ' ' VAL . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 69' ' ' VAL . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 56' ' ' ASN . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.63 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.38 -155.26 7.42 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -141.23 103.78 6.08 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 152.39 77.81 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.79 137.39 67.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.751 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.36 40.45 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.382 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.0 159.61 25.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -101.74 173.98 6.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.61 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.12 77.84 1.81 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.148 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 120.264 -0.186 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t 56.92 78.19 0.23 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.983 0.42 . . . . 0.0 110.996 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 56.48 76.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.393 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.06 167.21 30.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.358 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.79 106.79 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.745 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.93 148.63 48.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.513 0.197 . . . . 0.0 111.122 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.38 126.01 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 82' ' ' VAL . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.627 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.628 HD12 HD22 ' A' ' 80' ' ' LEU . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.56 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' A' ' 35' ' ' VAL . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 32' ' ' VAL . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.6 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 24' ' ' VAL . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 22' ' ' LEU . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG12 HG11 ' A' ' 35' ' ' VAL . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.954 HD11 HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.529 ' O ' HG22 ' A' ' 60' ' ' VAL . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 53' ' ' ILE . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 80' ' ' LEU . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG12 ' ND2' ' A' ' 56' ' ' ASN . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.954 HD23 HD11 ' A' ' 52' ' ' ILE . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -170.05 -151.49 7.44 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 75.91 79.41 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 110.541 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.57 110.68 2.57 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.898 2.398 . . . . 0.0 112.548 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.23 162.59 41.76 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.758 2.306 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.3 95.2 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.648 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.925 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.189 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.07 31.38 4.44 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.062 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -126.23 128.81 47.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.855 0.36 . . . . 0.0 111.004 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 45.17 0.84 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.529 ' C ' HD23 ' B' ' 97' ' ' LEU . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.529 HD23 ' C ' ' B' ' 96' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 56.65 74.55 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.938 0.399 . . . . 0.0 111.372 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -133.8 121.81 22.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -109.25 33.38 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.16 -82.18 0.23 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.869 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.21 178.92 4.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.64 0.257 . . . . 0.0 110.991 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.09 139.32 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.249 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 46' ' ' VAL . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 80' ' ' LEU . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB3' ' B' ' 96' ' ' ASP . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 11' ' ' VAL . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.871 HG12 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.746 HD12 ' OG1' ' A' ' 61' ' ' THR . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.746 ' OG1' HD12 ' A' ' 59' ' ' LEU . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' ASN . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 80' ' ' LEU . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.871 ' HG ' HG12 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 14.9 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.72 141.55 5.9 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -144.99 99.63 4.64 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.661 0.267 . . . . 0.0 111.095 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.59 159.79 22.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.774 2.316 . . . . 0.0 112.274 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.86 -177.13 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.054 2.503 . . . . 0.0 112.918 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.64 -43.54 0.35 Allowed Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.604 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.678 0.275 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -59.64 2.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -78.47 176.08 9.72 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.16 99.18 8.74 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.168 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.625 ' HB3' HG23 ' A' ' 23' ' ' THR . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 108.15 18.42 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.714 0.293 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 175.25 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 59.93 37.83 21.31 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.95 68.48 3.49 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.374 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 6' ' ' LEU . 3.4 mm? -110.35 125.74 53.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.149 0.18 . . . . 0.0 110.669 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.3 134.78 65.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.914 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 80' ' ' LEU . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HA ' ' B' ' 96' ' ' ASP . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.653 HG23 HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 22' ' ' LEU . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.914 HG22 HG11 ' A' ' 11' ' ' VAL . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 34' ' ' SER . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG23 HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.653 ' HE3' HG21 ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 52' ' ' ILE . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 78' ' ' VAL . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 60' ' ' VAL . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 HG21 ' B' ' 95' ' ' THR . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 71' ' ' LEU . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' CD1' HG12 ' A' ' 68' ' ' VAL . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 80' ' ' LEU . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 78' ' ' VAL . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.653 HG21 ' HE3' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.12 -143.49 3.87 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.65 101.14 3.73 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.78 170.1 14.74 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.98 132.16 38.2 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.601 2.201 . . . . 0.0 112.484 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.72 -38.79 30.88 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.667 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.535 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.446 0.165 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.8 87.68 7.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.96 135.71 54.46 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 79.82 1.34 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.505 HG21 HG22 ' A' ' 69' ' ' VAL . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.686 -0.165 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -73.15 -177.47 2.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -175.29 0.85 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.012 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.3 mtm -103.06 107.12 17.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.848 0.356 . . . . 0.0 111.572 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.51 -32.13 3.51 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.766 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.14 178.95 5.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.768 0.284 . . . . 0.0 111.053 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.98 123.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.967 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 81' ' ' THR . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.87 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.994 ' HB ' HG23 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 48' ' ' THR . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.87 HG22 HG21 ' A' ' 11' ' ' VAL . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' SER . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CD ' HG21 ' A' ' 81' ' ' THR . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 ' HG ' ' A' ' 80' ' ' LEU . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 28' ' ' ASN . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 71' ' ' LEU . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 72' ' ' ILE . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 73' ' ' LYS . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.742 HG23 HG11 ' A' ' 78' ' ' VAL . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 69' ' ' VAL . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG11 HG23 ' A' ' 72' ' ' ILE . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.494 HG23 ' SG ' ' A' ' 10' ' ' CYS . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.57 -167.54 17.98 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 145.69 31.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 51.3 Cg_exo -51.59 -49.45 17.15 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.918 2.412 . . . . 0.0 113.12 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 72.4 Cg_endo -75.1 135.2 18.58 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -172.02 101.7 0.17 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.462 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.845 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.688 0.28 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.04 154.3 19.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.4 160.57 32.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.25 60.5 1.7 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.434 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.533 HD21 HG21 ' A' ' 72' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB1' ' A' ' 79' ' ' ALA . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.795 HG11 HG22 ' A' ' 46' ' ' VAL . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.435 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.985 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 24' ' ' VAL . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 46' ' ' VAL . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.795 HG22 HG11 ' A' ' 11' ' ' VAL . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 52' ' ' ILE . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 53' ' ' ILE . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 28' ' ' ASN . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.592 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 HD11 ' A' ' 72' ' ' ILE . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.724 HG22 HG21 ' B' ' 95' ' ' THR . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 78' ' ' VAL . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HD2' HG12 ' A' ' 69' ' ' VAL . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG21 HG23 ' A' ' 72' ' ' ILE . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD12 ' CG1' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.797 ' CG1' HD12 ' A' ' 80' ' ' LEU . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.724 HG21 HG22 ' A' ' 69' ' ' VAL . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.525 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.873 0.368 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 81' ' ' THR . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.762 HG21 HG22 ' A' ' 46' ' ' VAL . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.52 ' HD2' HD22 ' B' ' 97' ' ' LEU . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 31' ' ' PHE . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 52' ' ' ILE . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 11' ' ' VAL . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.79 HD12 HG11 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG21 HG13 ' A' ' 68' ' ' VAL . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' CG2' ' A' ' 30' ' ' VAL . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG13 HG21 ' A' ' 55' ' ' VAL . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 78' ' ' VAL . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 72' ' ' ILE . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.624 HD22 ' HB ' ' A' ' 55' ' ' VAL . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.493 HG23 ' SG ' ' A' ' 10' ' ' CYS . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG22 ' A' ' 82' ' ' VAL . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 20' ' ' PHE . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 46' ' ' VAL . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.472 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 46' ' ' VAL . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CB ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 30' ' ' VAL . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 8.9 m120 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 48' ' ' THR . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' LEU . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 11' ' ' VAL . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 34' ' ' SER . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.756 HD11 ' CD ' ' A' ' 83' ' ' GLN . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG22 HD23 ' A' ' 80' ' ' LEU . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG23 ' A' ' 30' ' ' VAL . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HD12 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.626 ' O ' HG23 ' A' ' 68' ' ' VAL . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.519 ' HB ' HG21 ' B' ' 95' ' ' THR . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.667 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 55' ' ' VAL . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.756 ' CD ' HD11 ' A' ' 53' ' ' ILE . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.519 HG21 ' HB ' ' A' ' 69' ' ' VAL . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.799 HD11 ' HE2' ' A' ' 73' ' ' LYS . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.057 ' HB ' HG23 ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 51' ' ' ARG . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' HG23 ' A' ' 24' ' ' VAL . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 46' ' ' VAL . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.057 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.742 ' HB ' HD11 ' A' ' 72' ' ' ILE . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 30' ' ' VAL . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.458 ' OG1' HD22 ' A' ' 59' ' ' LEU . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG23 HD21 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.693 ' HE2' HD11 ' B' ' 97' ' ' LEU . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 80' ' ' LEU . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 78' ' ' VAL . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.54 ' O ' HD22 ' B' ' 97' ' ' LEU . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.693 HD21 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.94 0.4 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 46' ' ' VAL . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.965 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 36' ' ' LYS . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.435 HG23 ' HB3' ' B' ' 96' ' ' ASP . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.856 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.601 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m120 -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.049 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.856 ' HA ' HG12 ' A' ' 24' ' ' VAL . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.709 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 11' ' ' VAL . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.049 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' HG ' ' A' ' 80' ' ' LEU . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.718 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 28' ' ' ASN . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.718 ' OG1' HD22 ' A' ' 59' ' ' LEU . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.548 HG12 ' HE3' ' A' ' 73' ' ' LYS . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.588 HG23 HG21 ' A' ' 78' ' ' VAL . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.746 ' HE2' HD21 ' B' ' 97' ' ' LEU . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 72' ' ' ILE . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.652 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.965 HD13 HD12 ' A' ' 13' ' ' ILE . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 69' ' ' VAL . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 23' ' ' THR . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.746 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.885 0.374 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 20' ' ' PHE . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 13' ' ' ILE . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE ' ' A' ' 36' ' ' LYS . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 35' ' ' VAL . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 34' ' ' SER . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG12 HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m120 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.946 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 23' ' ' THR . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 22' ' ' LEU . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 35' ' ' VAL . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 34' ' ' SER . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.946 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 78' ' ' VAL . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 55' ' ' VAL . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.565 ' OG1' HD12 ' A' ' 59' ' ' LEU . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 68' ' ' VAL . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' NZ ' HD21 ' B' ' 97' ' ' LEU . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.865 HG23 HD11 ' A' ' 80' ' ' LEU . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.652 HG12 ' CB ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 53' ' ' ILE . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.454 HD21 ' NZ ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 HG13 HD13 ' A' ' 80' ' ' LEU . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' CG ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.026 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 22' ' ' LEU . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG12 HG11 ' A' ' 35' ' ' VAL . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 48' ' ' THR . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.026 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD12 ' OG1' ' A' ' 61' ' ' THR . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 59' ' ' LEU . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.464 ' O ' HG12 ' A' ' 68' ' ' VAL . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 68' ' ' VAL . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.629 HG13 HD11 ' A' ' 80' ' ' LEU . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 69' ' ' VAL . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.61 ' CG ' HG23 ' A' ' 23' ' ' THR . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 ' CG1' ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.619 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.6 m120 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.969 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 48' ' ' THR . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.969 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 60' ' ' VAL . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 80' ' ' LEU . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.64 ' O ' HG12 ' A' ' 68' ' ' VAL . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 65' ' ' HIS . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.858 HG12 ' HE3' ' A' ' 73' ' ' LYS . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.858 ' HE3' HG12 ' A' ' 69' ' ' VAL . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HD11 ' A' ' 80' ' ' LEU . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 78' ' ' VAL . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.687 0.279 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' NE2' HD12 ' A' ' 53' ' ' ILE . 34.4 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 46' ' ' VAL . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 22' ' ' LEU . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.675 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 48' ' ' THR . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 13' ' ' ILE . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 34' ' ' SER . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 60' ' ' VAL . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 80' ' ' LEU . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.712 ' CG ' HG23 ' A' ' 78' ' ' VAL . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 28' ' ' ASN . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 66' ' ' LEU . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 64' ' ' ASN . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.53 HG22 HG21 ' B' ' 95' ' ' THR . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 69' ' ' VAL . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.712 HG23 ' CG ' ' A' ' 56' ' ' ASN . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 53' ' ' ILE . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.53 HG21 HG22 ' A' ' 69' ' ' VAL . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.527 0.203 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.612 ' OE1' HD12 ' A' ' 53' ' ' ILE . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.555 HG21 HG22 ' A' ' 46' ' ' VAL . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.017 HD21 HG13 ' A' ' 24' ' ' VAL . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.017 HG13 HD21 ' A' ' 22' ' ' LEU . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 24' ' ' VAL . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 48' ' ' THR . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 22' ' ' LEU . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 11' ' ' VAL . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 33' ' ' GLN . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 60' ' ' VAL . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.871 ' O ' HG22 ' A' ' 58' ' ' THR . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 55' ' ' VAL . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 53' ' ' ILE . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 78' ' ' VAL . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG23 ' A' ' 72' ' ' ILE . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 55' ' ' VAL . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.054 0.454 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.667 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 44' ' ' ALA . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.764 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.668 HG23 ' CB ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 32' ' ' VAL . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.65 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.054 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 24' ' ' VAL . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.663 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG12 HG11 ' A' ' 35' ' ' VAL . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.734 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.054 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' HG ' ' A' ' 80' ' ' LEU . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.739 HG21 HD13 ' A' ' 71' ' ' LEU . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 60' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 66' ' ' LEU . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 58' ' ' THR . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 HG12 ' A' ' 68' ' ' VAL . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 72' ' ' ILE . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 52' ' ' ILE . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 24' ' ' VAL . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.668 ' CB ' HG23 ' A' ' 23' ' ' THR . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.89 0.376 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 46' ' ' VAL . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 80' ' ' LEU . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 32' ' ' VAL . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.611 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.024 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 24' ' ' VAL . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 46' ' ' VAL . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG22 HG21 ' A' ' 11' ' ' VAL . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' GLN . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.024 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' HD12 ' A' ' 59' ' ' LEU . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 69' ' ' VAL . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.478 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 80' ' ' LEU . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 82' ' ' VAL . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.428 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.931 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD22 ' B' ' 97' ' ' LEU . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD23 ' CB ' ' A' ' 41' ' ' ALA . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HB3' ' B' ' 96' ' ' ASP . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG13 ' B' ' 94' ' ' VAL . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB3' HG22 ' B' ' 94' ' ' VAL . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.565 HG13 ' HB1' ' A' ' 41' ' ' ALA . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' CB ' HD23 ' A' ' 22' ' ' LEU . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 35' ' ' VAL . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.671 ' O ' HG12 ' A' ' 60' ' ' VAL . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 68' ' ' VAL . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.578 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' OD1' ' A' ' 28' ' ' ASN . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 55' ' ' VAL . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.583 HG22 ' HE3' ' A' ' 73' ' ' LYS . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 55' ' ' VAL . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HE3' HG22 ' A' ' 69' ' ' VAL . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 80' ' ' LEU . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' ILE . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 24' ' ' VAL . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.751 ' HB3' HG23 ' A' ' 23' ' ' THR . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 20' ' ' PHE . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.735 0.302 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG22 ' A' ' 46' ' ' VAL . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.683 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 95' ' ' THR . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.688 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.064 ' HB ' HG23 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.835 HG22 HG11 ' A' ' 11' ' ' VAL . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 35' ' ' VAL . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.064 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.94 HG21 HG13 ' A' ' 68' ' ' VAL . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.466 HG23 HD22 ' A' ' 28' ' ' ASN . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.67 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.94 HG13 HG21 ' A' ' 55' ' ' VAL . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.721 HG22 ' HE3' ' A' ' 73' ' ' LYS . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.683 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' A' ' 69' ' ' VAL . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 72' ' ' ILE . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.746 0.307 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 82' ' ' VAL . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.674 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 32' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.407 ' OG ' HG22 ' B' ' 94' ' ' VAL . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 24' ' ' VAL . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.692 HG22 HG12 ' A' ' 24' ' ' VAL . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.792 HG12 HG23 ' A' ' 48' ' ' THR . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HA ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.792 HG23 HG12 ' A' ' 35' ' ' VAL . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.609 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HE2' HD23 ' A' ' 59' ' ' LEU . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 80' ' ' LEU . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 HG12 ' A' ' 78' ' ' VAL . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HE2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 53' ' ' ILE . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG12 HD11 ' A' ' 72' ' ' ILE . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.569 HG22 HG21 ' B' ' 95' ' ' THR . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 HG12 ' A' ' 68' ' ' VAL . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' NZ ' HD11 ' B' ' 97' ' ' LEU . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 72' ' ' ILE . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.407 HG22 ' OG ' ' A' ' 25' ' ' SER . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.45 HD11 ' NZ ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 22' ' ' LEU . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.788 ' HB2' HD22 ' B' ' 97' ' ' LEU . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.065 ' HB ' HG23 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 48' ' ' THR . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 22' ' ' LEU . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.813 HG22 HG11 ' A' ' 11' ' ' VAL . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 34' ' ' SER . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.065 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 72' ' ' ILE . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.612 HG23 HD21 ' A' ' 28' ' ' ASN . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 64' ' ' ASN . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 73' ' ' LYS . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 55' ' ' VAL . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 69' ' ' VAL . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 56' ' ' ASN . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.63 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 82' ' ' VAL . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.627 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.628 HD12 HD22 ' A' ' 80' ' ' LEU . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.56 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' A' ' 35' ' ' VAL . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 32' ' ' VAL . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.6 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 24' ' ' VAL . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 22' ' ' LEU . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG12 HG11 ' A' ' 35' ' ' VAL . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.954 HD11 HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.529 ' O ' HG22 ' A' ' 60' ' ' VAL . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 53' ' ' ILE . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 80' ' ' LEU . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG12 ' ND2' ' A' ' 56' ' ' ASN . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.954 HD23 HD11 ' A' ' 52' ' ' ILE . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.529 ' C ' HD23 ' B' ' 97' ' ' LEU . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.529 HD23 ' C ' ' B' ' 96' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 46' ' ' VAL . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 80' ' ' LEU . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB3' ' B' ' 96' ' ' ASP . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 11' ' ' VAL . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.871 HG12 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.746 HD12 ' OG1' ' A' ' 61' ' ' THR . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.746 ' OG1' HD12 ' A' ' 59' ' ' LEU . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' ASN . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 80' ' ' LEU . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.871 ' HG ' HG12 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 12.8 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.625 ' HB3' HG23 ' A' ' 23' ' ' THR . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.914 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 80' ' ' LEU . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HA ' ' B' ' 96' ' ' ASP . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.653 HG23 HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 22' ' ' LEU . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.914 HG22 HG11 ' A' ' 11' ' ' VAL . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 34' ' ' SER . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG23 HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.653 ' HE3' HG21 ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 52' ' ' ILE . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 78' ' ' VAL . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 60' ' ' VAL . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 HG21 ' B' ' 95' ' ' THR . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 71' ' ' LEU . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' CD1' HG12 ' A' ' 68' ' ' VAL . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 80' ' ' LEU . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 78' ' ' VAL . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.653 HG21 ' HE3' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.505 HG21 HG22 ' A' ' 69' ' ' VAL . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.688 0.28 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 81' ' ' THR . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.87 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.994 ' HB ' HG23 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 48' ' ' THR . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.87 HG22 HG21 ' A' ' 11' ' ' VAL . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' SER . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CD ' HG21 ' A' ' 81' ' ' THR . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 ' HG ' ' A' ' 80' ' ' LEU . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 28' ' ' ASN . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 71' ' ' LEU . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 72' ' ' ILE . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 73' ' ' LYS . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.742 HG23 HG11 ' A' ' 78' ' ' VAL . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 69' ' ' VAL . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG11 HG23 ' A' ' 72' ' ' ILE . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.494 HG23 ' SG ' ' A' ' 10' ' ' CYS . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.533 HD21 HG21 ' A' ' 72' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.2 p -97.38 162.22 13.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.661 0.267 . . . . 0.0 111.476 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 67.41 94.56 0.07 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -113.73 154.68 26.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.384 . . . . 0.0 111.355 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.11 -66.46 0.57 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -145.05 112.35 6.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.78 148.17 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.32 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -98.85 148.37 23.99 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 142.41 25.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB1' ' A' ' 79' ' ' ALA . 4.6 t -97.12 130.24 44.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.943 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.795 HG11 HG22 ' A' ' 46' ' ' VAL . 9.8 t -112.5 125.56 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.5 mp -96.42 110.61 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.702 0.287 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 22' ' ' LEU . 37.9 mt -105.03 131.32 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 27.7 mp0 -104.16 156.48 17.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 129.55 35.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.592 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -173.46 2.66 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.83 -35.94 71.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -94.67 -3.74 48.87 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 -159.54 29.87 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.707 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.75 -48.06 56.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.568 0.223 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.88 62.28 4.37 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.021 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 13' ' ' ILE . 3.5 pp -149.94 143.81 25.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.437 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -110.31 130.4 55.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.568 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.435 ' CG2' HG12 ' A' ' 30' ' ' VAL . 14.3 p -143.46 142.43 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 120.853 0.359 . . . . 0.0 111.639 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.56 161.76 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.908 0.385 . . . . 0.0 111.524 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 158.83 30.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.98 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' ASN . 4.1 p30 -105.94 -173.55 2.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 119.6 -0.238 . . . . 0.0 110.858 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.688 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 30.46 -92.33 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.864 0.727 . . . . 0.0 110.492 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.7 Cg_endo -77.73 63.47 8.03 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.44 1.426 . . . . 0.0 109.88 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.985 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.1 t -50.49 143.14 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.453 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 35.8 t80 -122.82 125.08 44.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.804 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 24' ' ' VAL . 21.9 t -75.6 128.07 37.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.44 -65.91 0.95 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 t -144.26 164.87 29.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.331 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 46' ' ' VAL . 4.9 m -138.01 149.54 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.85 108.31 3.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -32.34 61.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.57 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.49 45.61 1.28 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.19 -178.43 24.2 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.666 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.6 -35.65 54.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.28 -56.39 20.61 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.619 0.247 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.5 tpt -72.75 -38.59 67.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.717 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -35.01 74.4 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.123 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.27 60.76 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 27.67 7.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.795 HG22 HG11 ' A' ' 11' ' ' VAL . 16.4 t -94.89 139.56 18.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.782 0.291 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -113.07 169.19 9.11 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -79.84 116.9 20.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.467 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 92.53 69.17 1.13 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.573 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 165.09 15.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.508 0.194 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -113.97 83.51 1.88 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.212 . . . . 0.0 111.3 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.77 120.35 19.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 110.904 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -103.85 -35.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.836 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 81' ' ' THR . 2.3 mtpp -136.13 160.34 38.97 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.799 0.333 . . . . 0.0 111.712 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 52' ' ' ILE . 4.7 m -142.71 109.37 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.708 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.94 35.0 23.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.287 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.05 -43.56 2.84 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.156 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -67.63 109.21 3.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.303 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 5.6 mp -63.04 147.52 50.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 53' ' ' ILE . 11.1 m -91.26 30.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 28' ' ' ASN . 70.1 p -116.03 28.78 8.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.773 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -50.07 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -66.35 140.89 58.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -74.34 -177.57 3.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.592 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.2 t-80 -57.73 -65.14 0.68 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.786 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.45 -29.88 66.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.936 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.51 -55.06 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.242 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 HD11 ' A' ' 72' ' ' ILE . 9.2 p -58.75 -38.7 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.724 HG22 HG21 ' B' ' 95' ' ' THR . 21.3 t -62.31 -48.88 86.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -58.35 -41.08 83.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -47.89 78.77 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.043 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 78' ' ' VAL . 13.1 mt -66.45 -42.13 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.52 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HD2' HG12 ' A' ' 69' ' ' VAL . 21.3 mttm -67.77 -27.77 67.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.325 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -75.51 68.43 2.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.109 0.481 . . . . 0.0 110.956 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.93 151.52 5.54 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -68.22 -58.96 3.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.784 0.292 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 45.9 p90 -118.89 151.16 38.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.019 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG21 HG23 ' A' ' 72' ' ' ILE . 23.9 m -148.49 149.48 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.916 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -96.81 141.62 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.205 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD12 ' CG1' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -128.24 119.91 26.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 111.99 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 54' ' ' LYS . 5.6 m -81.37 106.95 13.75 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.797 ' CG1' HD12 ' A' ' 80' ' ' LEU . 5.2 m -121.13 176.02 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.606 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -138.63 146.29 41.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.02 -154.22 6.08 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.811 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.29 148.8 35.88 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.403 0.144 . . . . 0.0 110.619 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 57.5 Cg_endo -71.54 110.64 2.92 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.612 2.208 . . . . 0.0 112.294 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 53.5 Cg_endo -70.27 108.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.581 2.188 . . . . 0.0 112.176 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.57 66.62 1.7 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.227 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.069 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.403 0.144 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.05 111.17 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.078 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -113.81 43.33 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.772 0.32 . . . . 0.0 111.706 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.77 42.18 0.79 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 111.316 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.16 137.48 37.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.281 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.724 HG21 HG22 ' A' ' 69' ' ' VAL . 24.1 m -137.74 128.52 27.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.407 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.62 123.24 45.68 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.525 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.894 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -85.25 70.51 10.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.949 0.404 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -141.38 24.7 2.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.99 31.88 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.599 0.238 . . . . 0.0 111.505 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.99 22.34 1.6 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 6' ' ' LEU . 15.4 mt -156.62 74.63 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.837 0.351 . . . . 0.0 110.288 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.02 140.13 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.1 141.75 35.3 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.999 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.82 141.25 24.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.442 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 81' ' ' THR . 16.5 m -96.77 122.3 39.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.762 HG21 HG22 ' A' ' 46' ' ' VAL . 27.8 m -106.73 132.76 53.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -99.53 110.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.643 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -99.26 130.95 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.265 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -113.12 121.5 44.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.691 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.78 131.18 45.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.289 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.92 -166.89 1.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.897 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -32.6 68.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.23 12.13 27.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.734 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.65 -158.18 47.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.579 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.52 ' HD2' HD22 ' B' ' 97' ' ' LEU . 28.3 m-85 -84.52 -47.48 10.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.701 0.286 . . . . 0.0 110.879 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.89 63.13 3.62 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.778 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 pp -150.18 141.94 23.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.924 0.392 . . . . 0.0 111.704 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.4 m -110.67 129.23 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.006 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 31' ' ' PHE . 21.8 t -136.99 142.01 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -137.68 155.22 49.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.517 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.56 -178.53 21.75 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.614 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.09 -94.66 0.35 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.932 0.366 . . . . 0.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 m-80 -47.45 -62.17 2.31 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -92.18 69.14 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.773 2.315 . . . . 0.0 110.517 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 52' ' ' ILE . 11.9 t -43.67 143.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -128.91 123.77 33.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.609 0.242 . . . . 0.0 111.558 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.09 117.64 38.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -83.4 -79.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.759 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -114.9 148.67 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.843 0.354 . . . . 0.0 111.386 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.4 m -137.15 147.44 26.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -59.73 92.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.18 -32.04 15.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.47 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 49.82 1.18 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -156.82 -171.82 23.39 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.796 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.71 39.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 -59.93 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.15 65.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.045 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -60.02 -32.5 70.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.757 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.19 -14.77 59.32 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.74 20.45 10.76 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.777 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 11' ' ' VAL . 8.2 t -94.73 134.42 32.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.767 0.284 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -125.13 165.51 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.0 p -72.71 144.09 47.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.807 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.01 61.55 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.991 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.12 120.0 40.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.784 0.292 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 3.7 mtt180 -85.16 116.85 23.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.937 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.79 HD12 HG11 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -79.1 145.65 9.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 112.008 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.5 mm -95.49 -45.48 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.771 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . 5.8 ptpt -160.55 169.23 23.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.787 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG21 HG13 ' A' ' 68' ' ' VAL . 7.2 m -126.97 127.26 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.35 43.9 29.19 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.559 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.03 36.04 91.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.981 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 9.8 m -127.78 99.64 5.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.649 0.262 . . . . 0.0 110.726 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.4 mt -57.77 133.01 55.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' CG2' ' A' ' 30' ' ' VAL . 10.7 m -92.98 35.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.325 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.6 p -110.65 -38.27 5.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -119.83 28.16 8.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -128.91 163.88 24.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.672 0.273 . . . . 0.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-80 -82.36 151.98 26.42 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.313 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -63.7 -63.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.88 -32.22 31.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.88 -38.63 86.29 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.812 0.339 . . . . 0.0 110.35 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG13 HG21 ' A' ' 55' ' ' VAL . 22.6 t -62.37 -53.57 45.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.3 -38.7 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.085 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -61.02 -46.27 91.42 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.746 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -63.93 -46.64 83.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.012 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 78' ' ' VAL . 16.0 mt -64.93 -41.68 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.562 0.22 . . . . 0.0 110.834 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -68.04 -31.78 71.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.7 p -81.76 66.48 7.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.05 150.62 6.03 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.05 -62.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.63 0.215 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -122.01 156.46 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 72' ' ' ILE . 4.5 m -149.44 149.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.564 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.51 111.17 23.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.036 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.624 HD22 ' HB ' ' A' ' 55' ' ' VAL . 1.8 mt -105.55 129.07 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 112.051 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.493 HG23 ' SG ' ' A' ' 10' ' ' CYS . 3.7 m -80.76 106.26 12.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.882 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 12.8 p -116.37 160.89 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.054 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG22 ' A' ' 82' ' ' VAL . 14.2 tt0 -139.48 151.5 46.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.023 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 172.73 42.78 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.755 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -120.06 80.06 26.5 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.633 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.78 130.41 37.12 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.747 2.298 . . . . 0.0 112.156 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.15 112.16 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.823 2.348 . . . . 0.0 112.698 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 -91.8 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.12 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 71.66 163.48 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.88 148.66 51.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.6 48.38 2.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.12 137.41 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.47 102.42 5.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.888 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.48 139.58 44.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 20' ' ' PHE . 4.0 mp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.085 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -99.21 -36.36 9.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.511 0.195 . . . . 0.0 111.485 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -97.73 126.73 43.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.547 0.213 . . . . 0.0 111.327 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ptm -141.81 136.76 30.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.67 71.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.781 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.79 127.98 12.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.637 0.256 . . . . 0.0 111.196 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.08 133.99 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.411 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -116.55 142.94 46.22 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -149.81 156.09 41.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.3 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 77.0 m -88.36 129.48 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 46' ' ' VAL . 21.6 t -114.27 120.52 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.118 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.472 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.7 mp -98.54 121.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 46' ' ' VAL . 22.3 mt -121.69 133.31 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -95.28 169.71 9.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 117.4 30.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.14 -173.69 3.17 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.66 -36.27 69.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.42 13.74 32.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.51 -144.61 17.18 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.443 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -90.26 -37.8 13.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.557 0.218 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.2 63.76 4.11 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.885 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CB ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -149.33 136.58 19.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.341 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -107.23 132.14 53.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.596 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 30' ' ' VAL . 13.3 p -144.7 142.09 23.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.448 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.8 p -140.94 162.54 35.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.69 155.4 31.92 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.072 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -102.05 -170.44 1.82 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.634 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 8.9 m120 30.3 -91.08 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.664 0.603 . . . . 0.0 110.947 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.679 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 96.5 Cg_endo -78.81 57.91 6.62 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.679 1.586 . . . . 0.0 110.245 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 21.3 t -49.01 140.88 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.198 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -123.78 127.01 47.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.07 116.0 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.204 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -64.8 -67.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.212 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 48' ' ' THR . 1.9 t -147.81 162.3 39.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' LEU . 4.9 m -137.36 152.52 27.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -58.39 113.28 1.9 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.82 -24.0 55.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.711 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.97 56.27 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.96 0.41 . . . . 0.0 110.573 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.7 -168.88 13.97 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.057 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.92 -41.84 64.83 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.283 0.233 . . . . 0.0 111.554 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -54.5 46.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.986 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -64.13 -48.21 76.98 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.385 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -63.18 -27.61 69.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.34 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.66 -14.85 59.51 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.18 8.2 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.865 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 11' ' ' VAL . 20.6 t -94.89 150.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.872 0.368 . . . . 0.0 111.48 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.78 166.54 16.63 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.2 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 34' ' ' SER . 93.1 m -81.8 127.9 33.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.569 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.98 46.98 4.02 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.627 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.29 11.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.476 0.179 . . . . 0.0 110.619 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' A' ' 83' ' ' GLN . 10.5 ttt180 -119.62 87.79 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.73 0.3 . . . . 0.0 111.121 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -75.13 130.35 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.406 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.756 HD11 ' CD ' ' A' ' 83' ' ' GLN . 6.4 mt -114.99 -37.91 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.609 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.8 tppt? -128.8 160.62 31.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 111.866 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG22 HD23 ' A' ' 80' ' ' LEU . 21.9 t -138.36 103.99 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.161 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' ALA . 3.2 m-20 62.73 31.4 16.61 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.66 -33.74 5.01 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.962 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -77.44 109.28 11.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.014 0.435 . . . . 0.0 110.682 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -63.85 159.22 20.08 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG23 ' A' ' 30' ' ' VAL . 17.8 m -93.12 37.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HD12 ' A' ' 59' ' ' LEU . 6.4 m -112.05 19.15 18.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.81 63.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 p -163.43 157.28 19.66 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 111.704 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.626 ' O ' HG23 ' A' ' 68' ' ' VAL . 22.8 m120 -91.76 161.56 14.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -56.14 -64.38 0.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.125 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.4 mt -57.71 -31.45 66.43 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.7 tp10 -61.02 -49.71 76.29 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.662 0.268 . . . . 0.0 111.048 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.7 t -60.98 -52.67 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.51 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.519 ' HB ' HG21 ' B' ' 95' ' ' THR . 12.9 p -60.45 -42.68 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.611 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -61.31 -47.12 87.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.546 0.212 . . . . 0.0 110.941 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -46.55 90.07 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.667 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -65.25 -38.5 82.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -65.06 -32.24 73.85 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.198 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.46 66.65 4.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.59 151.3 6.75 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -63.81 -60.19 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.587 0.232 . . . . 0.0 110.945 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -121.82 164.31 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -148.2 145.07 18.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.772 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -102.45 141.65 34.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.263 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 55' ' ' VAL . 5.2 mp -137.78 121.46 17.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.656 0.265 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 10.7 m -76.94 102.38 6.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.96 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.3 m -116.32 175.21 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.334 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.756 ' CD ' HD11 ' A' ' 53' ' ' ILE . 16.4 pt20 -148.93 154.16 39.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 143.99 6.46 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.747 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.19 96.0 49.15 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-O 120.692 0.282 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 113.28 3.37 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.698 2.265 . . . . 0.0 112.117 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.35 128.13 28.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.813 2.342 . . . . 0.0 112.704 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.3 74.67 0.96 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.377 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.926 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.577 0.227 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -113.48 134.78 54.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.789 0.328 . . . . 0.0 111.183 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.07 38.26 1.76 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -131.55 66.18 1.55 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.16 137.03 50.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.782 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.519 HG21 ' HB ' ' A' ' 69' ' ' VAL . 2.0 m -143.88 135.72 26.32 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.044 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -141.36 153.9 45.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.295 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.799 HD11 ' HE2' ' A' ' 73' ' ' LYS . 3.4 mm? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 27.91 4.81 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.259 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -175.33 -61.68 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.606 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.5 mmm 66.25 160.17 0.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.98 -95.67 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.74 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 85' ' ' ARG . 64.5 mt -115.79 170.32 8.55 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.853 0.359 . . . . 0.0 111.067 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.82 141.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.027 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -98.87 138.59 35.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -147.8 153.93 39.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 m -96.56 120.77 37.49 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.777 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -107.58 126.57 63.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.956 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.0 mp -94.97 111.12 25.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.64 129.52 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 1.7 pt20 -106.43 125.69 51.32 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.17 137.82 56.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.966 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.99 -178.36 3.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.283 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.95 -34.87 66.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.99 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -94.82 13.93 23.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.514 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.81 53.64 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.881 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -82.2 -44.79 15.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.784 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 52.12 4.71 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.2 pp -150.09 142.27 24.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.873 0.368 . . . . 0.0 111.471 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -115.34 121.77 43.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.365 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 30' ' ' VAL . 6.1 p -118.88 150.61 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t -136.14 161.67 35.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.909 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.32 175.59 37.46 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.12 -84.18 0.61 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.724 0.262 . . . . 0.0 111.477 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -48.91 -61.88 2.89 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.4 Cg_endo -96.84 73.19 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.406 2.737 . . . . 0.0 110.264 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.057 ' HB ' HG23 ' A' ' 52' ' ' ILE . 2.6 t -53.95 124.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 51' ' ' ARG . 12.7 t80 -116.74 124.11 48.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.599 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' HG23 ' A' ' 24' ' ' VAL . 19.4 t -79.51 116.74 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.277 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.17 -75.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.873 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.04 147.09 40.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 46' ' ' VAL . 15.5 m -138.25 153.29 26.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.138 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -59.21 124.09 18.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.849 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.19 -35.69 81.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.09 55.04 1.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.9 -171.63 15.57 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.735 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.72 -35.47 55.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.56 -60.57 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.961 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.16 -41.37 73.9 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.089 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -58.76 -35.25 72.45 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.31 -13.03 60.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.11 13.46 24.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.051 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -95.39 120.37 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.83 0.315 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -101.93 168.2 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 t -76.09 69.2 2.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.65 51.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.971 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.03 174.54 5.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -128.92 81.9 2.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.983 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.057 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.96 129.96 34.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.51 0.671 . . . . 0.0 111.097 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.5 mp -115.12 -34.28 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.705 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 3.0 ttmt -129.45 156.33 44.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.366 . . . . 0.0 111.779 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.742 ' HB ' HD11 ' A' ' 72' ' ' ILE . 23.2 m -139.86 104.92 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.76 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 59.54 48.62 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.87 24.12 71.31 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.668 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 103.66 8.27 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.1 OUTLIER -65.25 132.98 50.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.939 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 30' ' ' VAL . 13.4 m -71.96 -9.16 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.458 ' OG1' HD22 ' A' ' 59' ' ' LEU . 1.2 p -59.81 -32.95 71.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.664 0.268 . . . . 0.0 110.796 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -112.91 31.43 6.41 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 m -138.27 133.02 32.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.074 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 m-20 -84.14 -177.65 6.72 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -57.13 -65.36 0.63 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 mp -58.03 -27.8 63.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -65.65 -50.68 64.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.491 0.186 . . . . 0.0 111.303 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.3 t -61.1 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.19 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG23 HD21 ' B' ' 97' ' ' LEU . 11.7 p -58.27 -41.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.86 -41.38 95.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.978 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.96 -47.78 64.8 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.8 mm -64.31 -43.26 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.993 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.693 ' HE2' HD11 ' B' ' 97' ' ' LEU . 5.8 ttmt -67.73 -29.16 68.32 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.354 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -79.31 67.33 5.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.904 0.383 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.88 157.9 8.53 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 m -73.24 -66.65 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.548 0.213 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 38.3 p90 -118.4 153.8 33.47 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 80' ' ' LEU . 8.7 m -149.75 148.18 15.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.046 0.45 . . . . 0.0 111.981 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.89 111.83 24.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.13 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 78' ' ' VAL . 5.1 mp -106.08 131.47 53.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 88.9 m -85.37 112.33 20.74 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.968 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.5 m -122.96 174.74 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -131.3 143.61 50.65 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.17 144.8 4.18 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.656 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HB2' HD22 ' A' ' 6' ' ' LEU . 41.1 mtp85 -124.3 146.21 51.12 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.72 0.295 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.25 153.72 45.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.688 2.258 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 125.91 11.9 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.717 2.278 . . . . 0.0 112.382 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.79 -132.41 1.77 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.7 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.794 0.33 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.58 117.18 27.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 110.84 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -121.29 166.92 13.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.968 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.09 102.81 11.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -102.33 137.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.52 153.06 46.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 111.077 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.54 ' O ' HD22 ' B' ' 97' ' ' LEU . 2.6 p-10 -134.3 121.64 21.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.224 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.693 HD21 HG23 ' A' ' 69' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.002 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 m -110.74 136.54 49.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.16 -178.99 3.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.3 mtt 66.28 -177.58 0.19 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.68 103.05 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.282 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.1 mp -74.07 147.47 42.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.837 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 m -107.79 143.52 18.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.408 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -99.04 143.62 29.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -144.1 141.07 29.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.3 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -100.36 135.6 41.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.643 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 46' ' ' VAL . 5.9 m -129.75 132.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.231 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -95.05 110.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.523 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.965 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -96.28 131.65 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 28.1 mt-30 -116.34 118.96 34.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -59.51 131.0 49.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.28 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.87 -172.1 2.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.556 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.85 -33.38 61.71 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.21 12.06 34.2 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.56 -172.24 35.82 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.66 -52.24 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.607 0.242 . . . . 0.0 110.705 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 36' ' ' LYS . . . 69.46 70.3 1.2 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.176 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.11 142.41 24.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.435 HG23 ' HB3' ' B' ' 96' ' ' ASP . 4.2 m -115.13 121.55 43.36 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.327 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.856 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.1 m -131.63 144.56 37.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 111.64 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -119.02 160.33 22.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.647 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.45 -175.63 37.7 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.397 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.38 -79.54 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.937 0.368 . . . . 0.0 111.606 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.601 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m120 -52.19 -61.74 4.08 Favored Pre-proline 0 N--CA 1.464 0.265 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.1 Cg_endo -94.91 70.12 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.103 2.535 . . . . 0.0 110.529 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.049 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.3 t -51.9 123.64 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.705 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 29.1 t80 -109.83 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.077 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.856 ' HA ' HG12 ' A' ' 24' ' ' VAL . 17.4 t -89.85 122.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.402 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -118.31 13.72 13.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.99 131.11 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.643 0.258 . . . . 0.0 111.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.709 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 30.1 m -138.25 142.43 35.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.226 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -54.67 134.93 47.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.36 -37.85 51.38 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.476 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -126.93 55.17 1.57 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.41 -165.94 12.78 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.509 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.0 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.6 -51.79 64.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 6.5 tpt -75.76 -41.93 51.77 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.972 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -59.03 -35.24 72.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.381 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.83 -14.41 59.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.36 24.32 19.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.886 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 11' ' ' VAL . 11.8 t -95.02 121.44 45.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -103.6 162.86 12.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -73.3 140.39 46.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.94 38.37 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.835 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.76 174.72 8.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.622 0.249 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.8 mtt85 -132.0 84.52 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.529 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.049 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.99 121.96 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.319 0.581 . . . . 0.0 110.646 179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mt -109.2 -33.4 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.793 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 ttmt -127.68 153.15 46.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.801 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' HG ' ' A' ' 80' ' ' LEU . 26.0 m -139.6 107.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.739 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.11 28.84 16.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.685 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 -28.85 8.11 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.833 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 p -81.53 105.61 12.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.313 . . . . 0.0 110.711 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.718 HD22 ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -64.72 148.32 51.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 28' ' ' ASN . 9.6 m -94.1 30.75 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.915 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.718 ' OG1' HD22 ' A' ' 59' ' ' LEU . 88.7 m -77.03 -34.66 57.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 110.601 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -121.75 31.14 6.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 m -117.21 146.54 43.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -86.22 163.85 17.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.38 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -54.43 -61.61 2.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.51 -36.6 71.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.013 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.11 -40.06 76.3 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.317 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.5 t -65.36 -45.16 94.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.655 0.264 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.548 HG12 ' HE3' ' A' ' 73' ' ' LYS . 14.1 t -60.17 -54.86 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.209 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -57.89 -38.69 76.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.685 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -48.3 74.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.485 0.184 . . . . 0.0 111.013 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.588 HG23 HG21 ' A' ' 78' ' ' VAL . 24.0 mt -66.78 -45.42 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.619 0.247 . . . . 0.0 110.556 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.746 ' HE2' HD21 ' B' ' 97' ' ' LEU . 12.2 mttt -67.7 -26.75 66.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.678 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -32.57 64.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.38 15.05 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -58.44 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.639 0.257 . . . . 0.0 110.719 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 31.4 p90 -120.62 144.96 47.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.846 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 72' ' ' ILE . 13.4 m -149.81 149.54 14.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.652 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -91.31 141.28 28.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.83 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.965 HD13 HD12 ' A' ' 13' ' ' ILE . 9.1 mp -133.48 128.3 35.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 86.8 m -91.98 111.45 22.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.772 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.8 m -119.38 175.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.678 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.81 150.43 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.03 -156.01 8.22 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.734 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -61.45 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.131 0.173 . . . . 0.0 111.198 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 111.16 1.43 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.568 2.178 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 113.05 3.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.819 2.346 . . . . 0.0 112.512 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.72 52.01 0.73 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.835 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.215 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.461 0.172 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -89.2 -60.47 1.94 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.791 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.23 178.46 8.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 50.28 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 m -102.83 137.24 31.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 69' ' ' VAL . 1.9 m -119.41 153.81 34.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 23' ' ' THR . 7.4 p-10 -156.61 122.45 4.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.736 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.746 HD21 ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.282 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.697 -0.161 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.29 -75.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.422 0.289 . . . . 0.0 111.341 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.42 174.09 0.14 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.255 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 177.77 0.14 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 111.222 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.08 -110.3 0.36 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.149 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD23 ' HG2' ' A' ' 83' ' ' GLN . 0.1 OUTLIER 63.15 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.06 138.94 42.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.393 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -98.83 138.15 36.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 150.43 40.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.337 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.6 m -96.73 118.85 34.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.859 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -106.65 128.69 61.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.9 mp -97.3 110.95 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 20' ' ' PHE . 29.9 mt -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.663 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 44.5 mt-30 -116.2 141.97 47.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.968 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 113.11 22.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -108.69 -170.3 1.64 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -56.72 -35.99 69.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.243 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -93.54 6.39 48.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.67 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.13 -173.16 36.11 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 13' ' ' ILE . 24.1 m-85 -69.9 -55.7 9.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.826 0.346 . . . . 0.0 110.234 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE ' ' A' ' 36' ' ' LYS . . . 69.21 57.47 7.55 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.005 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 35' ' ' VAL . 2.6 pp -150.0 144.65 25.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.901 0.35 . . . . 0.0 111.627 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 34' ' ' SER . 3.4 t -117.02 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG12 HG12 ' A' ' 30' ' ' VAL . 2.4 t -126.62 142.68 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.44 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -138.72 162.18 35.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 93.89 150.46 26.84 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.134 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 28' ' ' ASN . 7.5 p-10 -96.32 -165.62 1.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.754 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m120 21.87 -86.78 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 123.999 0.812 . . . . 0.0 111.193 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 92.3 Cg_endo -79.6 59.92 7.6 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.948 1.766 . . . . 0.0 110.199 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.946 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.8 t -49.82 153.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.462 . . . . 0.0 111.937 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.34 133.14 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.657 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.54 -64.79 1.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 23' ' ' THR . 53.1 p -125.41 144.79 50.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.479 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 22' ' ' LEU . 11.7 m -137.83 144.39 31.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.861 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 1.7 mttt -58.67 118.34 5.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -66.31 -41.54 89.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -111.34 42.79 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.64 178.31 18.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.364 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . . . -50.47 -33.87 22.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.15 -64.03 0.96 Allowed 'General case' 0 C--N 1.338 0.088 0 CA-C-O 120.66 0.267 . . . . 0.0 110.822 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 mtp -70.44 -33.55 71.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -40.71 84.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 110.805 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -77.61 -14.41 59.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.021 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.62 17.94 9.41 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.166 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 35' ' ' VAL . 11.2 t -94.95 121.36 45.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.92 0.36 . . . . 0.0 110.709 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -111.57 175.51 5.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.242 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 34' ' ' SER . 53.2 p -77.21 149.33 35.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.11 50.02 49.06 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.268 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.62 111.68 24.47 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.425 0.155 . . . . 0.0 111.039 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -69.89 82.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.584 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.946 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.17 130.47 35.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.4 mp -112.68 -37.38 2.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.532 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 1.3 tptt -124.88 149.34 47.63 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 111.375 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 14.3 m -129.15 108.65 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 78' ' ' VAL . 4.1 t30 57.93 47.43 15.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.02 72.07 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.713 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.9 m -133.19 108.62 8.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.729 0.3 . . . . 0.0 110.395 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -64.03 138.11 58.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 55' ' ' VAL . 18.8 m -105.84 34.41 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.261 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.565 ' OG1' HD12 ' A' ' 59' ' ' LEU . 33.5 p -79.29 -30.95 43.16 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -124.22 38.36 4.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 110.752 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -121.67 166.59 14.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -105.22 174.45 5.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -56.19 -60.71 3.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -52.97 -31.61 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.447 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.09 -43.55 98.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.591 0.234 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -64.62 -52.55 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.162 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.1 p -61.0 -42.26 92.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.295 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -41.31 96.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.819 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -47.84 68.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.185 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 68' ' ' VAL . 17.8 mt -65.17 -42.77 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.761 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' NZ ' HD21 ' B' ' 97' ' ' LEU . 1.3 ttmm -67.83 -28.27 67.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -75.99 68.01 2.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.45 151.01 5.35 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.297 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -53.07 35.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 30.4 p90 -127.86 156.33 42.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.865 HG23 HD11 ' A' ' 80' ' ' LEU . 5.3 m -149.98 149.41 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.573 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.49 111.08 23.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.504 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -108.03 131.19 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.85 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -85.96 115.87 23.84 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.919 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.652 HG12 ' CB ' ' A' ' 52' ' ' ILE . 13.0 m -123.11 175.84 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HG2' HD23 ' A' ' 6' ' ' LEU . 4.2 tt0 -138.21 151.09 47.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.53 168.25 25.0 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.013 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -165.67 129.39 1.66 Allowed Pre-proline 0 C--O 1.233 0.233 0 C-N-CA 122.04 0.136 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.51 110.04 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.836 2.357 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.66 170.53 16.24 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.805 2.337 . . . . 0.0 112.679 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.46 71.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.622 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.082 -179.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.19 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.94 -161.8 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -54.36 161.14 1.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 111.349 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 132.57 49.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.373 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.75 137.33 39.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -133.43 145.95 50.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -134.14 129.07 35.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.219 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.454 HD21 ' NZ ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.787 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -85.0 165.49 17.52 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.726 0.298 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 156.16 43.08 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.304 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.73 159.2 16.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.463 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.77 44.65 0.02 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.925 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 59.76 -179.87 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.03 118.31 46.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 137.02 38.36 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -144.21 146.88 32.96 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.6 m -104.73 122.4 45.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.98 129.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.095 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.2 mp -97.09 120.76 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 HG13 HD13 ' A' ' 80' ' ' LEU . 30.6 mt -97.59 132.29 42.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.0 mm-40 -117.87 109.92 17.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -62.11 138.98 58.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.34 -166.26 1.81 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.79 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -57.18 -35.5 69.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.924 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.12 -14.06 56.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.523 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 -158.16 26.99 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.536 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -77.99 -50.38 12.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.599 0.238 . . . . 0.0 110.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.88 64.4 4.39 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.282 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.03 136.02 22.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.663 0.268 . . . . 0.0 111.539 -179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.61 HG23 ' CG ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -105.46 130.33 53.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.899 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 30' ' ' VAL . 15.9 t -141.31 148.26 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -138.66 160.56 39.32 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.975 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.81 176.22 36.72 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.808 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.37 -84.76 0.58 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.696 0.248 . . . . 0.0 111.571 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -50.14 -58.56 9.23 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.0 Cg_endo -97.84 69.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.558 2.838 . . . . 0.0 110.61 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.026 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.7 t -54.19 129.12 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -123.21 123.76 41.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.738 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 22' ' ' LEU . 43.2 t -74.79 120.13 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.83 -65.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.43 155.83 44.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.983 0.421 . . . . 0.0 111.57 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -132.35 136.35 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.19 115.07 3.83 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.321 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -61.67 -32.18 72.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.44 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.54 48.12 1.16 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.022 0.439 . . . . 0.0 110.837 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.84 -173.09 21.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.78 60.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.54 -53.24 57.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.28 -40.08 45.83 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.794 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -34.5 72.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.266 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.29 -14.62 60.11 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.12 27.29 13.89 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.79 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG12 HG11 ' A' ' 35' ' ' VAL . 21.9 t -94.91 137.73 22.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.258 . . . . 0.0 110.659 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -103.65 173.82 6.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.379 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 48' ' ' THR . 7.2 t -86.76 101.48 13.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.291 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 46.26 0.36 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.924 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.1 160.21 14.44 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -117.5 84.89 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.556 0.217 . . . . 0.0 111.235 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.026 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.83 131.33 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.496 0.665 . . . . 0.0 111.396 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -115.86 -37.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.684 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -132.25 168.22 18.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 4.8 m -144.1 112.05 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.12 35.89 23.89 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.46 -45.03 2.58 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.556 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -71.4 122.99 21.34 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.876 0.37 . . . . 0.0 110.878 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD12 ' OG1' ' A' ' 61' ' ' THR . 0.5 OUTLIER -81.35 146.4 30.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.003 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.19 45.31 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.928 0.394 . . . . 0.0 111.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 59' ' ' LEU . 36.6 p -98.02 22.03 9.92 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.782 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.74 52.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -134.65 171.82 13.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.377 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 7.6 m-20 -86.2 169.46 13.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.341 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' O ' HG12 ' A' ' 68' ' ' VAL . 32.9 t-80 -70.95 -65.27 0.76 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.1 mt -62.2 -24.47 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.163 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.4 mp0 -70.4 -51.97 25.75 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.458 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 65' ' ' HIS . 12.7 p -60.43 -42.72 92.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -67.35 -43.31 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.42 0.153 . . . . 0.0 111.006 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -40.09 95.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -47.25 70.46 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.975 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 68' ' ' VAL . 28.2 mt -66.87 -36.88 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.576 0.227 . . . . 0.0 110.524 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -68.06 -28.86 67.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.02 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -78.03 66.93 3.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.157 0.504 . . . . 0.0 110.99 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.73 151.29 6.93 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.931 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 t -68.97 -66.1 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.858 0.329 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -120.7 158.36 27.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.629 HG13 HD11 ' A' ' 80' ' ' LEU . 13.1 p -157.19 148.77 10.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.617 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 80' ' ' LEU . . . -90.3 142.06 28.1 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.234 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 55' ' ' VAL . 6.4 mp -131.12 116.09 17.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.849 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -80.67 107.05 13.15 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.629 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 52' ' ' ILE . 2.8 m -123.26 175.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.18 0.514 . . . . 0.0 112.186 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.05 153.49 49.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.33 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.65 24.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.829 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -101.77 152.54 38.13 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.553 0.216 . . . . 0.0 110.84 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.88 111.67 2.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.69 2.26 . . . . 0.0 112.083 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.2 97.41 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.42 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.79 -67.44 3.66 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.353 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.095 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.68 86.59 0.11 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-O 121.086 0.47 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.84 -178.4 6.25 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -146.01 48.48 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.019 0.438 . . . . 0.0 111.122 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.23 136.93 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 69' ' ' VAL . 27.4 m -131.64 115.49 16.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.61 ' CG ' HG23 ' A' ' 23' ' ' THR . 29.4 t0 -116.7 132.62 56.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.032 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.197 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.86 29.81 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -173.32 123.84 0.39 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.3 39.74 3.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.61 27.86 56.26 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.966 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD22 ' CD ' ' A' ' 83' ' ' GLN . 2.0 mt -154.33 141.09 19.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.738 0.269 . . . . 0.0 110.715 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.38 144.58 37.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.49 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.72 144.28 28.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -149.49 138.69 21.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 p -102.37 134.91 44.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.831 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.98 132.98 70.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.319 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.8 mp -101.4 111.38 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.26 131.87 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 9.0 mt-30 -114.21 124.84 53.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.02 130.39 46.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 -172.46 2.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.19 -36.28 75.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.032 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.0 -10.0 49.22 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.392 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -171.18 40.54 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.456 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.84 -52.38 20.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.505 0.193 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.19 70.08 1.19 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.657 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -149.96 141.57 23.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -106.02 121.81 44.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 ' CG1' ' A' ' 30' ' ' VAL . 3.0 t -122.81 156.12 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.12 161.29 38.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.982 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.04 -177.37 47.76 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.587 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.15 -79.53 0.48 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.755 0.277 . . . . 0.0 111.541 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.619 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.6 m120 -52.62 -64.19 1.75 Allowed Pre-proline 0 C--N 1.342 0.258 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.6 Cg_endo -92.15 73.13 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.881 2.388 . . . . 0.0 110.05 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.969 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.0 t -53.09 125.39 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.769 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -119.28 123.67 44.82 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -84.4 118.86 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.343 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.03 -65.58 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.8 151.43 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.87 0.367 . . . . 0.0 111.382 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.2 m -135.41 153.54 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.376 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.56 131.88 50.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.27 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -78.98 -30.33 44.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.408 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -119.5 51.67 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.01 19.13 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.652 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.67 -38.57 55.53 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.3 -57.3 11.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.876 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 2.2 tpt -69.36 -40.47 77.44 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -35.06 71.54 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.585 0.231 . . . . 0.0 110.806 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.95 58.93 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 29.29 7.37 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.691 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.26 147.26 5.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.672 0.272 . . . . 0.0 110.709 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.3 167.02 13.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.14 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 48' ' ' THR . 13.0 t -84.81 105.84 15.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.87 49.92 0.57 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.893 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.96 164.67 12.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 111.018 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -118.31 84.59 2.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.969 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.48 125.45 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.828 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 60' ' ' VAL . 8.4 mt -110.38 -28.6 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.545 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -135.46 154.77 51.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.68 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 80' ' ' LEU . 33.5 t -139.35 108.57 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.584 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.97 48.45 8.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.63 18.96 59.86 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.924 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.3 m -114.69 108.43 16.78 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -63.95 128.99 38.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.02 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.7 p -94.2 29.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.066 0.46 . . . . 0.0 111.042 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 -39.44 21.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.742 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -116.57 32.88 5.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -120.07 157.5 28.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.71 167.84 14.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.027 0.441 . . . . 0.0 111.41 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.64 ' O ' HG12 ' A' ' 68' ' ' VAL . 35.8 t-80 -67.69 -65.87 0.63 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.67 -29.03 51.61 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.333 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.64 -54.9 39.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.615 0.245 . . . . 0.0 111.262 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 65' ' ' HIS . 10.7 p -59.62 -35.64 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.04 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.858 HG12 ' HE3' ' A' ' 73' ' ' LYS . 5.7 t -63.04 -50.53 79.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.389 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -59.02 -39.12 80.94 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.82 -47.88 76.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.634 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 mt -66.31 -41.63 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.571 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.858 ' HE3' HG12 ' A' ' 69' ' ' VAL . 8.8 mtmt -66.02 -31.61 72.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.068 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -83.23 65.59 8.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.43 159.44 12.22 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.388 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.37 -66.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.631 0.215 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 49.6 p90 -122.03 152.59 39.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.702 0.287 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HD11 ' A' ' 80' ' ' LEU . 24.2 m -148.53 149.13 15.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.843 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -101.48 111.51 23.77 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.109 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 78' ' ' VAL . 3.1 mp -106.65 130.95 54.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.887 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 95.5 m -89.7 114.57 26.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.011 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 52' ' ' ILE . 3.1 m -122.75 175.93 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.944 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.419 ' CD ' HD22 ' A' ' 6' ' ' LEU . 33.5 tt0 -138.39 150.35 46.44 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.487 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.71 -149.88 8.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.944 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 80.25 20.59 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.73 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.37 152.72 66.3 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.642 2.228 . . . . 0.0 112.324 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.85 149.74 66.73 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.536 2.157 . . . . 0.0 112.582 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 34.38 30.64 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.773 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.264 179.845 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.601 0.239 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.39 168.5 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 67.82 169.82 0.27 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.61 66.85 0.84 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.73 137.03 32.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 144.8 44.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.0 122.64 11.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.216 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.61 42.58 1.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.08 169.76 15.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.8 105.0 4.17 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.189 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 6' ' ' LEU . . . -110.78 -39.7 1.4 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.807 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 84' ' ' GLY . 5.5 mt 66.59 156.85 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 86' ' ' PRO . 18.8 t -128.12 122.06 57.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.518 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' NE2' HD12 ' A' ' 53' ' ' ILE . 34.4 tt0 -99.05 139.9 34.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -149.03 141.25 24.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 t -96.77 124.27 40.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.805 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.41 129.33 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.0 mp -106.79 112.82 41.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 46' ' ' VAL . 28.7 mt -107.01 131.44 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 124.25 49.16 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.5 131.56 51.11 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.27 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 -176.36 3.58 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.42 -33.66 74.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -90.84 13.08 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.445 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.15 -167.08 49.6 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -75.81 -42.86 48.74 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.613 0.244 . . . . 0.0 110.628 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 36' ' ' LYS . . . 65.49 66.31 2.5 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.178 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -149.8 137.18 19.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.252 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 121.68 44.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG1' ' CG1' ' A' ' 30' ' ' VAL . 21.9 t -130.43 145.57 35.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 161.61 36.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.576 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 172.28 42.61 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.368 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.6 -82.65 0.64 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.089 0.444 . . . . 0.0 111.857 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -50.07 -62.55 2.48 Favored Pre-proline 0 N--CA 1.464 0.238 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.7 Cg_endo -94.4 71.47 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.074 2.516 . . . . 0.0 110.241 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 52' ' ' ILE . 19.1 t -53.54 128.09 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.501 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.8 t80 -121.53 124.83 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.842 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 22' ' ' LEU . 39.7 t -85.9 129.82 37.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.948 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -95.88 -75.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.764 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.675 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -106.95 148.92 28.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.418 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 48' ' ' THR . 32.4 m -131.97 150.35 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.524 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' CG ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -56.68 127.22 30.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.75 -33.07 70.42 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.426 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -140.74 60.87 1.52 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.42 -165.88 13.35 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.579 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.3 -33.22 27.87 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . . . -58.22 -63.8 1.14 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.167 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -34.8 78.3 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -63.7 -38.35 90.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.78 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -14.78 59.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.764 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.19 23.71 21.48 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.658 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 13' ' ' ILE . 22.1 t -94.52 125.41 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.631 0.253 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -109.13 175.35 5.49 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.338 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 34' ' ' SER . 19.5 p -78.75 138.6 38.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.989 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 31' ' ' PHE . . . 82.47 38.87 11.6 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.666 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.77 120.5 39.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -81.51 82.08 7.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 111.388 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.55 134.55 29.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 60' ' ' VAL . 48.1 mt -107.86 -42.31 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.838 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -130.97 153.65 48.98 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 80' ' ' LEU . 26.8 m -126.28 113.44 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.965 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.712 ' CG ' HG23 ' A' ' 78' ' ' VAL . 1.9 t30 59.37 49.63 8.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.23 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.02 65.38 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.532 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.52 116.15 19.95 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mp -63.51 125.73 25.2 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 30' ' ' VAL . 33.5 m -95.5 27.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.285 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 28' ' ' ASN . 13.0 p -106.61 32.33 4.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.851 0.357 . . . . 0.0 110.866 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -163.81 -43.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.28 171.8 2.23 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 111.602 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -92.73 173.88 7.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.647 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -62.06 -65.3 0.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 66' ' ' LEU . 2.7 mm? -51.47 -34.78 37.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.181 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -46.74 86.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.647 0.261 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 64' ' ' ASN . 40.1 t -59.5 -52.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.53 HG22 HG21 ' B' ' 95' ' ' THR . 21.1 t -58.41 -46.48 89.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -57.24 -43.67 83.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.1 -47.9 78.22 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 78' ' ' VAL . 36.1 mt -64.26 -43.55 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.844 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 69' ' ' VAL . 19.1 mttm -68.06 -30.46 69.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.508 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -80.89 66.96 6.61 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.58 149.61 5.59 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.0 t -65.1 -56.93 10.14 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.615 0.245 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -120.48 165.08 15.45 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.712 HG23 ' CG ' ' A' ' 56' ' ' ASN . 7.5 p -148.33 133.71 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.64 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -103.17 110.65 22.68 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.917 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -107.93 131.81 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.903 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 23.3 m -85.45 114.69 22.68 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.751 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 52' ' ' ILE . 5.5 m -120.21 173.79 5.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.161 0.505 . . . . 0.0 112.261 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 53' ' ' ILE . 5.9 mt-30 -142.45 150.95 41.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.391 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' HD23 ' A' ' 6' ' ' LEU . . . -131.35 -148.21 6.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.292 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -140.81 123.54 9.78 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.566 0.183 . . . . 0.0 110.669 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 7' ' ' VAL . 45.4 Cg_exo -56.44 166.94 3.04 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.78 2.32 . . . . 0.0 112.281 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 127.82 19.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.348 2.032 . . . . 0.0 111.751 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.36 -96.89 0.02 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.045 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 90' ' ' VAL . 16.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.727 0.299 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -150.64 123.53 8.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -124.29 146.91 48.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -112.11 83.03 1.73 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.85 137.2 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.53 HG21 HG22 ' A' ' 69' ' ' VAL . 34.0 m -136.47 118.64 15.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.232 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.09 121.54 34.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.468 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.545 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 CA-C-O 120.21 -0.217 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -118.51 12.86 13.35 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.92 0.36 . . . . 0.0 111.509 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.49 23.27 7.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mmt -155.52 179.2 9.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.826 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.63 73.83 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.598 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 83' ' ' GLN . 1.0 OUTLIER -119.89 101.46 7.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.017 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.25 149.07 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.612 ' OE1' HD12 ' A' ' 53' ' ' ILE . 4.9 tt0 -98.73 136.32 38.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.794 0.331 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -150.04 149.29 30.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.687 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.6 m -101.67 118.92 37.93 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.555 HG21 HG22 ' A' ' 46' ' ' VAL . 6.4 m -112.89 132.06 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mt -103.68 110.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.45 133.92 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.403 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 6.6 mt-30 -109.83 147.49 33.22 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.07 142.49 54.48 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.8 0.334 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.69 172.69 11.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -59.71 -28.3 67.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.47 13.26 35.54 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.525 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.17 -171.07 45.8 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.29 -55.61 17.35 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.705 0.288 . . . . 0.0 110.663 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 52.34 3.89 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.313 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.017 HD21 HG13 ' A' ' 24' ' ' VAL . 1.4 tt -150.13 140.28 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.765 0.317 . . . . 0.0 111.129 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.11 121.62 43.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.017 HG13 HD21 ' A' ' 22' ' ' LEU . 3.5 m -119.24 146.26 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.532 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 11.5 t -134.99 162.49 32.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.559 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 -177.03 48.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.73 -82.53 0.53 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.851 0.325 . . . . 0.0 111.517 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -48.73 -62.22 2.53 Favored Pre-proline 0 N--CA 1.464 0.234 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 63.5 Cg_endo -98.34 69.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.564 2.843 . . . . 0.0 110.373 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.997 ' HB ' HG23 ' A' ' 52' ' ' ILE . 24.9 t -53.96 126.59 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 25' ' ' SER . 23.1 p90 -120.31 124.79 46.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.037 0.446 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 24' ' ' VAL . 27.4 t -75.95 115.36 17.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.625 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 48' ' ' THR . 22.4 tp60 -69.75 -64.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -141.1 152.43 44.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 22' ' ' LEU . 5.2 m -136.88 153.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.534 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 110.66 1.31 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.4 -36.19 61.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.447 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.98 49.43 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.81 -175.27 13.88 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.29 52.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.3 -61.72 2.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.605 0.24 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.3 tpp -66.03 -37.46 85.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.968 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -62.1 -35.95 80.25 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.83 60.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.63 20.86 8.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 11' ' ' VAL . 23.9 t -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.637 0.256 . . . . 0.0 110.781 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -121.1 174.13 6.85 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 33' ' ' GLN . 86.7 m -81.29 134.83 35.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.604 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.13 27.76 43.67 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.85 175.45 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -135.47 84.0 2.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.243 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.65 130.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 60' ' ' VAL . 76.5 mt -114.53 -34.26 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.942 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 9.8 mtpp -133.04 158.99 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.871 ' O ' HG22 ' A' ' 58' ' ' THR . 22.0 t -143.93 106.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.368 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 61.39 28.71 18.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.068 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.54 3.06 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 55' ' ' VAL . 5.7 t -59.96 143.18 52.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.27 140.75 29.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.064 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 53' ' ' ILE . 35.1 m -94.97 29.95 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.344 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -100.59 -51.33 3.63 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.477 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -89.08 -29.38 19.45 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -64.39 158.2 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 m120 -95.3 177.04 5.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.383 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.33 -64.16 1.04 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.7 mp -55.68 -29.75 59.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.18 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.18 -47.24 87.05 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.51 0.195 . . . . 0.0 110.964 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 21.4 t -61.91 -53.0 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.209 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.7 p -61.64 -42.93 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.737 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -63.86 -47.77 79.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 78' ' ' VAL . 16.9 mt -65.56 -42.14 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.725 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 69' ' ' VAL . 10.7 mttt -68.27 -30.41 69.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.91 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 p -77.38 68.59 3.51 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.065 0.46 . . . . 0.0 111.066 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.96 145.48 4.14 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.034 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.7 t -62.72 -59.9 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.689 0.281 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 8.7 p90 -117.68 151.5 37.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.642 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG23 ' A' ' 72' ' ' ILE . 15.5 m -151.76 149.36 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.53 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -95.8 141.54 29.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.17 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 55' ' ' VAL . 3.6 mp -137.74 125.47 22.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 11.5 m -84.66 106.74 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.57 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.0 m -119.88 175.6 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 111.953 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.512 ' OE1' HD12 ' A' ' 6' ' ' LEU . 24.7 tt0 -146.97 138.2 24.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 147.08 135.43 2.69 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.563 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.04 125.2 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 122.666 0.387 . . . . 0.0 111.407 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 112.05 2.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.558 2.172 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.76 112.24 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.797 2.332 . . . . 0.0 112.424 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.42 -61.65 0.63 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.746 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.562 HG22 ' H ' ' B' ' 92' ' ' ASN . 12.3 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.05 35.15 3.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.562 ' H ' HG22 ' B' ' 90' ' ' VAL . 3.0 m120 -104.64 99.78 9.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 47.35 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 137.48 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.84 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.667 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -128.23 153.14 47.26 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.965 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.85 152.29 44.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.49 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 112.845 -0.102 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -92.29 157.16 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.333 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.18 106.2 4.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.0 tpt -116.35 151.87 35.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.47 47.97 1.06 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.982 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.4 mm? 61.37 105.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 p -108.95 128.83 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.24 147.78 24.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -140.65 135.94 32.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.335 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -104.78 129.87 52.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.846 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 44' ' ' ALA . 32.0 t -128.63 130.52 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.469 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -97.79 115.95 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.162 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.764 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 mm -92.37 133.4 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 2.1 tt0 -112.18 160.18 17.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.675 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -87.48 126.01 34.65 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.443 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.32 -179.68 3.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.784 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -34.41 70.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.048 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -100.57 13.09 35.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.322 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.63 -168.02 53.38 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -67.83 -51.45 48.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.65 0.262 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.02 68.26 1.68 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.912 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.92 152.46 35.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.668 HG23 ' CB ' ' B' ' 96' ' ' ASP . 0.2 OUTLIER -120.61 139.56 52.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.394 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 32' ' ' VAL . 22.6 m -140.13 146.73 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.099 0.476 . . . . 0.0 112.005 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -133.93 140.73 46.98 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.668 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 -173.22 15.93 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.219 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -133.76 -85.16 0.44 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.801 0.3 . . . . 0.0 111.559 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.65 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 4.0 m-20 -53.22 -55.5 33.5 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -98.83 64.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.639 2.893 . . . . 0.0 110.878 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.054 ' HB ' HG23 ' A' ' 52' ' ' ILE . 38.9 t -49.71 134.02 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.314 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 54.9 t80 -119.68 124.06 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 111.536 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 24' ' ' VAL . 21.6 t -81.48 117.92 28.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.05 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -77.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.843 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.5 m -108.09 145.76 33.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 111.403 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.663 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 24.4 m -137.68 148.88 25.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -57.9 108.54 0.6 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.17 -34.24 66.0 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -126.58 54.94 1.55 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.128 0.49 . . . . 0.0 110.506 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -148.73 -171.98 18.08 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.426 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -36.57 53.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -53.96 -59.64 4.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.088 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -39.56 68.91 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.954 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.37 -33.26 69.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -80.22 -15.24 57.45 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.7 -9.94 25.73 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.935 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG12 HG11 ' A' ' 35' ' ' VAL . 16.1 t -64.59 147.69 12.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 117.029 0.415 . . . . 0.0 110.963 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -140.02 154.97 47.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.734 HG22 ' HA ' ' A' ' 34' ' ' SER . 69.3 p -67.53 113.92 5.76 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 111.92 42.06 1.04 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.852 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.45 160.51 19.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.98 87.09 2.65 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.054 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.83 128.17 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.294 0.568 . . . . 0.0 111.05 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 mt -111.05 -37.73 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.581 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -128.47 159.78 34.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.858 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' HG ' ' A' ' 80' ' ' LEU . 18.7 t -144.52 103.68 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.445 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.62 31.84 18.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.344 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.16 -29.73 7.35 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.739 HG21 HD13 ' A' ' 71' ' ' LEU . 2.0 m -64.6 106.87 1.25 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.788 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.83 127.81 33.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.701 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 60' ' ' VAL . 5.6 t -93.84 24.12 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 -41.8 29.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.661 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.81 35.01 4.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.74 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 m -97.75 166.97 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 m120 -103.96 163.12 12.58 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -56.49 -66.1 0.5 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -59.84 -29.11 68.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -42.81 99.93 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 64' ' ' ASN . 25.6 t -64.05 -52.98 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 66' ' ' LEU . 11.6 p -60.56 -43.36 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.286 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -40.39 91.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.037 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 58' ' ' THR . 5.6 tt -69.54 -47.88 62.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 HG12 ' A' ' 68' ' ' VAL . 12.8 mt -64.22 -44.61 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.665 0.269 . . . . 0.0 110.732 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -67.64 -27.08 66.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.659 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -76.89 68.29 3.05 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 110.976 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.03 150.96 5.5 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -58.03 5.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.002 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 37.9 p90 -122.69 152.01 40.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.836 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 72' ' ' ILE . 24.1 m -147.63 149.28 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -89.94 141.51 28.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.967 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 52' ' ' ILE . 4.4 mp -131.63 118.51 20.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.883 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 54' ' ' LYS . 93.3 m -89.31 106.37 18.4 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.713 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 ' CB ' ' A' ' 52' ' ' ILE . 3.4 m -116.57 174.8 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.083 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.02 154.06 42.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.34 162.4 24.82 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.676 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -144.06 99.55 5.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-O 120.679 0.276 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 51.5 Cg_exo -53.43 -45.84 38.17 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.839 2.36 . . . . 0.0 112.975 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 31.8 Cg_exo -58.77 124.79 16.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.371 2.047 . . . . 0.0 112.632 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.78 -79.29 0.26 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.116 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.574 -179.395 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.464 HG23 ' H ' ' B' ' 91' ' ' GLU . 3.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.464 ' H ' HG23 ' B' ' 90' ' ' VAL . 0.0 OUTLIER -134.53 154.08 51.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.674 0.273 . . . . 0.0 111.083 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 66.33 107.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.426 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -128.41 56.2 1.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.975 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -116.53 138.49 46.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 24' ' ' VAL . 79.4 m -135.46 114.18 11.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.668 ' CB ' HG23 ' A' ' 23' ' ' THR . 4.4 p30 -114.08 157.21 22.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.129 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.909 -0.077 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -109.7 176.51 5.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -147.47 -66.49 0.26 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mpp? 67.44 153.66 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.75 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.39 44.15 2.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.327 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.64 172.88 8.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.683 HG21 ' HD3' ' A' ' 87' ' ' PRO . 34.4 m -128.03 135.39 62.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.853 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.13 136.43 40.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.647 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.97 132.95 31.1 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -94.13 118.78 32.03 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 46' ' ' VAL . 13.0 p -109.45 128.32 65.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.3 mp -100.2 110.9 28.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 80' ' ' LEU . 2.8 pt -100.77 133.77 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 27.4 mt-30 -114.8 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 128.27 35.01 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.166 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.0 -173.12 2.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.05 -36.29 76.97 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.077 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -13.95 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.625 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.77 179.38 44.73 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -63.82 -54.43 35.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.607 0.241 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.73 57.14 8.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.805 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.3 pp -150.26 136.06 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 0.0 111.071 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.7 p -109.23 123.24 48.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 32' ' ' VAL . 29.9 m -118.36 147.75 21.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 111.528 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -136.6 162.73 32.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.554 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -165.19 32.11 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.471 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -142.74 -84.18 0.17 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.014 0.407 . . . . 0.0 111.782 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.611 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -51.3 -62.33 3.04 Favored Pre-proline 0 C--O 1.233 0.195 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 61.8 Cg_endo -96.57 68.32 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.256 2.638 . . . . 0.0 110.419 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.024 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.7 t -51.62 133.69 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.464 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -127.03 124.25 38.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.022 0.439 . . . . 0.0 111.467 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 24' ' ' VAL . 24.2 t -76.8 119.63 25.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.59 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 5.2 tp60 -77.85 -61.25 2.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.419 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.8 t -133.99 149.54 51.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 111.155 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 46' ' ' VAL . 13.7 m -137.83 144.5 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 105.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -52.82 -29.42 27.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.443 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.98 48.36 1.33 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.529 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.8 -178.36 18.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.87 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . . . -49.36 -44.9 45.13 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.63 1.56 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.586 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.51 -46.64 87.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.817 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -27.39 68.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.303 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -82.37 -14.86 54.56 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.87 13.15 9.53 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.089 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG22 HG21 ' A' ' 11' ' ' VAL . 17.1 t -95.09 114.4 31.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.007 0.403 . . . . 0.0 110.82 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 168.77 8.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' GLN . 20.2 m -68.27 121.84 17.08 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.25 57.33 1.14 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.796 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 160.35 17.89 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.573 0.225 . . . . 0.0 110.791 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -121.39 80.07 1.62 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.657 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.024 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.4 122.42 19.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.354 0.597 . . . . 0.0 111.128 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.6 mt -102.62 -37.04 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.656 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.4 mttm -136.36 159.2 42.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.574 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.096 HG12 HD23 ' A' ' 80' ' ' LEU . 26.9 m -133.2 113.7 19.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.98 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.7 t30 57.86 33.61 23.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.83 -32.08 5.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.1 m -77.19 113.93 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -57.3 136.54 56.54 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.967 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 55' ' ' VAL . 9.6 m -97.91 37.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' HD12 ' A' ' 59' ' ' LEU . 13.8 p -107.35 18.92 21.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -141.35 -48.26 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -55.02 143.22 27.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 111.517 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.26 175.92 4.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -63.76 -55.78 20.56 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -73.11 -25.34 60.82 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.998 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -69.64 -49.72 51.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 69' ' ' VAL . 14.5 p -62.61 -45.37 98.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.503 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' B' ' 95' ' ' THR . 11.2 p -64.63 -42.07 94.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.452 0.167 . . . . 0.0 111.005 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.01 94.22 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.706 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.13 -47.8 75.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.478 HD11 ' HB ' ' A' ' 55' ' ' VAL . 42.5 mm -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.723 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -66.85 -30.2 70.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -30.5 71.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.421 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.33 157.79 20.46 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.37 -74.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.476 0.179 . . . . 0.0 110.714 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.1 p90 -118.49 147.36 43.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 80' ' ' LEU . 9.5 m -151.15 149.81 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.008 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -98.08 110.93 23.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.096 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -105.35 131.85 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 112.057 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 4.0 m -79.49 110.07 14.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.575 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 21.6 t -116.49 162.36 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.786 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 82' ' ' VAL . 48.1 tt0 -129.65 146.91 51.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.77 -145.01 4.04 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.899 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.79 158.02 37.18 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.576 0.227 . . . . 0.0 110.712 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.57 128.92 27.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.09 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.683 ' HD3' HG21 ' A' ' 7' ' ' VAL . 50.2 Cg_exo -53.84 104.89 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.873 2.382 . . . . 0.0 112.54 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.74 -103.48 0.81 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.709 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.005 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.454 HG23 ' H ' ' B' ' 91' ' ' GLU . 3.6 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.454 ' H ' HG23 ' B' ' 90' ' ' VAL . 4.7 pt-20 -120.22 174.55 6.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -166.81 137.82 3.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.299 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -144.53 68.77 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.925 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.48 137.43 40.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.428 HG21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -117.72 147.21 43.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.117 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.48 125.7 24.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.501 -0.762 . . . . 0.0 111.668 -179.513 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 120.393 -0.115 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.58 132.85 53.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.767 0.318 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.12 40.24 22.14 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.468 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtp -93.26 154.72 17.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.28 -125.93 2.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.788 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -156.62 151.57 26.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.5 136.0 60.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.268 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.0 136.39 39.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.651 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -149.76 155.07 39.51 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.957 0.408 . . . . 0.0 111.852 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -100.87 136.61 40.46 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.024 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.97 131.83 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.823 0.344 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.1 mp -95.14 117.15 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.931 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -112.13 130.59 65.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.437 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 77' ' ' TYR . 41.4 tt0 -103.65 114.62 29.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.79 141.11 58.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -175.75 2.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.5 -34.73 67.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.263 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -95.66 14.03 24.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.752 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.12 -163.05 37.45 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.604 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD22 ' B' ' 97' ' ' LEU . 88.9 m-85 -80.98 -41.25 23.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.593 0.235 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.79 36.42 13.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.733 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD23 ' CB ' ' A' ' 41' ' ' ALA . 1.8 pp -138.27 150.66 46.88 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.483 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HB3' ' B' ' 96' ' ' ASP . 11.7 m -114.36 132.27 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.293 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG13 ' B' ' 94' ' ' VAL . 6.1 t -132.56 141.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB3' HG22 ' B' ' 94' ' ' VAL . 0.7 OUTLIER -140.05 162.03 36.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.412 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.97 155.23 31.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -104.27 -174.48 2.55 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.711 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 48.4 m-20 35.55 -95.06 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 123.61 0.568 . . . . 0.0 110.412 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 86.6 Cg_endo -77.94 63.28 8.12 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.466 1.444 . . . . 0.0 109.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 41.8 t -50.83 148.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.04 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.33 135.81 43.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 111.792 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.87 127.56 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.0 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -84.97 -68.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.349 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -119.27 149.55 41.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.874 0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG13 ' HB1' ' A' ' 41' ' ' ALA . 21.8 t -136.91 134.6 48.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 103.3 1.74 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.4 -33.53 54.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.397 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -107.26 31.51 5.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.401 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.25 170.79 21.3 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.83 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.07 -32.34 34.25 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' CB ' HD23 ' A' ' 22' ' ' LEU . . . -58.12 -63.82 1.13 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.687 0.28 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.49 78.93 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.623 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -33.82 74.25 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.124 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.16 -13.8 60.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.35 19.42 6.25 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.234 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 35' ' ' VAL . 23.3 t -94.95 138.75 20.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 117.13 0.465 . . . . 0.0 110.558 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 152.68 44.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.245 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 t -64.2 138.14 58.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 28.97 53.85 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.914 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.61 173.41 12.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.743 0.271 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.33 81.18 1.98 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.71 124.92 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.332 0.587 . . . . 0.0 111.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.671 ' O ' HG12 ' A' ' 60' ' ' VAL . 54.6 mt -104.71 -36.01 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.558 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 15.3 mttt -136.27 152.78 51.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.666 0.269 . . . . 0.0 111.653 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 68' ' ' VAL . 31.5 m -123.46 113.32 37.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.126 0.489 . . . . 0.0 111.052 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.578 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.5 t30 57.87 38.05 27.04 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.029 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.15 -35.84 3.7 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.173 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 p -64.04 151.95 41.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.022 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.44 129.08 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.823 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.3 p -93.17 28.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 111.04 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' OD1' ' A' ' 28' ' ' ASN . 50.6 m -89.93 -35.39 15.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.06 37.25 4.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -114.69 158.83 21.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 111.369 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m120 -88.8 172.45 9.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.235 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.5 -66.3 0.67 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.082 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.59 -30.03 62.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.495 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.17 -47.09 84.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.47 0.176 . . . . 0.0 111.223 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 55' ' ' VAL . 47.8 t -62.84 -52.65 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.352 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.583 HG22 ' HE3' ' A' ' 73' ' ' LYS . 12.0 p -59.19 -42.56 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.355 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.71 -40.23 94.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.504 0.192 . . . . 0.0 111.049 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.63 -47.88 68.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.898 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 55' ' ' VAL . 40.6 mm -65.52 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.898 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HE3' HG22 ' A' ' 69' ' ' VAL . 9.1 ttmt -66.99 -32.03 73.0 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.921 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 m -81.37 66.05 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.75 34.52 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.545 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.5 m -87.35 -68.58 0.74 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.486 0.184 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 39.2 p90 -121.46 159.1 26.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 80' ' ' LEU . 11.8 m -146.67 148.65 16.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.709 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.53 110.58 23.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.691 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.931 HD13 HD12 ' A' ' 13' ' ' ILE . 6.7 mp -101.5 125.89 48.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 111.853 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 2.4 m -85.73 108.02 17.86 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.401 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.2 m -121.19 176.17 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.129 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.646 ' CG ' HD23 ' A' ' 6' ' ' LEU . 2.1 tm0? -139.38 137.72 35.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.78 177.54 28.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.8 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.9 mtt180 -97.99 109.62 52.31 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.87 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.858 2.372 . . . . 0.0 112.457 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.42 77.33 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.075 2.516 . . . . 0.0 112.366 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.11 75.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.113 -179.691 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.517 0.199 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 57.78 72.04 0.54 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.301 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -157.94 -52.21 0.07 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.769 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -126.98 72.97 1.38 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 110.97 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 24' ' ' VAL . 32.7 t -108.91 136.88 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -135.46 125.9 26.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.751 ' HB3' HG23 ' A' ' 23' ' ' THR . 23.2 p-10 -138.57 153.79 48.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 20' ' ' PHE . 2.4 mp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.409 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.37 -75.56 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.622 0.211 . . . . 0.0 110.793 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.46 125.1 28.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.904 0.383 . . . . 0.0 111.343 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 91.73 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 -115.17 0.38 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.768 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.712 HD21 ' HD3' ' A' ' 85' ' ' ARG . 3.7 mp -105.79 171.09 7.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.672 0.273 . . . . 0.0 110.947 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.57 122.95 62.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.17 137.84 37.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -137.31 146.15 44.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -106.05 118.87 37.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.655 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG22 ' A' ' 46' ' ' VAL . 26.1 t -102.44 131.71 50.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -99.86 110.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -106.87 134.15 49.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.15 115.6 29.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 20' ' ' PHE . 4.7 tttm -61.72 138.79 58.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -123.89 179.73 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.748 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.82 -34.86 70.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.656 0.265 . . . . 0.0 110.988 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -14.29 55.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.644 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.82 -157.58 19.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.583 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.683 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 49.5 m-85 -94.44 -48.84 5.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.632 0.253 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.46 67.82 1.82 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.954 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.14 150.1 31.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.984 0.392 . . . . 0.0 111.729 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -106.52 134.44 49.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 95' ' ' THR . 14.1 p -145.62 143.78 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.812 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 p -139.34 160.35 40.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.764 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 -179.11 24.58 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -132.12 -92.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.688 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m120 -49.8 -55.93 20.4 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -97.97 67.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.592 2.861 . . . . 0.0 110.515 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.064 ' HB ' HG23 ' A' ' 52' ' ' ILE . 25.0 t -51.15 138.36 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.539 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.42 124.18 35.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.607 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.9 110.88 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.006 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.14 -66.55 0.54 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.35 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.54 162.37 34.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.366 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 5.5 m -131.53 152.89 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.191 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.32 130.21 41.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -71.96 -24.84 61.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.395 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -135.49 52.65 2.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.469 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.34 13.49 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.105 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.22 63.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -57.29 -50.06 74.11 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.852 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -71.59 -41.51 68.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.656 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -35.86 75.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.86 -13.37 60.55 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.33 34.4 8.7 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.835 HG22 HG11 ' A' ' 11' ' ' VAL . 23.6 t -93.22 138.61 19.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.708 0.289 . . . . 0.0 110.786 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -96.65 174.29 6.9 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 35' ' ' VAL . 28.6 p -96.35 88.44 4.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.916 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 71.9 0.21 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.721 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -126.96 147.61 50.1 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.547 0.213 . . . . 0.0 111.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -93.51 84.93 4.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.064 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.18 125.81 31.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 110.883 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.98 -40.12 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.647 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 8.2 mttp -131.77 155.24 48.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.841 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.94 HG21 HG13 ' A' ' 68' ' ' VAL . 22.9 m -129.82 116.64 38.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.469 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.43 37.79 22.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.75 28.2 69.48 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.674 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 119.24 20.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.612 0.244 . . . . 0.0 110.688 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.06 144.81 54.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.378 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.5 t -97.43 35.51 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.057 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.466 HG23 HD22 ' A' ' 28' ' ' ASN . 27.3 m -99.72 -51.27 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.299 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.93 -31.23 16.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -64.1 152.4 40.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.299 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.67 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.0 m-80 -91.35 172.71 8.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -65.49 -63.92 0.98 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.391 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.7 mt -56.48 -30.97 63.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -46.92 86.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.094 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.94 HG13 HG21 ' A' ' 55' ' ' VAL . 44.9 t -62.69 -52.81 55.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.472 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.721 HG22 ' HE3' ' A' ' 73' ' ' LYS . 11.5 p -59.5 -42.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.503 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -61.57 -45.23 95.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.21 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.86 -46.4 89.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.879 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.683 HG22 ' CZ ' ' A' ' 20' ' ' PHE . 12.9 mt -65.28 -43.54 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.623 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' A' ' 69' ' ' VAL . 1.1 mtmt -65.88 -32.66 74.3 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.218 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.43 62.92 7.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.23 148.16 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.748 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 t -84.04 -29.67 26.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -132.13 139.87 48.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 72' ' ' ILE . 26.8 m -144.99 135.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.778 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.03 111.67 24.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.409 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.3 mp -100.7 128.91 46.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 22.7 m -91.28 108.01 19.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.5 m -120.53 175.91 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.147 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -141.24 150.02 42.11 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.708 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.86 177.7 23.17 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.009 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.712 ' HD3' HD21 ' A' ' 6' ' ' LEU . 26.9 ptt180 -171.57 155.2 3.97 Favored Pre-proline 0 N--CA 1.463 0.222 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 19.4 Cg_endo -58.34 109.76 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 47.3 Cg_endo -69.36 151.38 71.35 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.548 2.165 . . . . 0.0 112.44 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.65 44.04 27.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.208 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.263 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.556 HG23 ' H ' ' B' ' 92' ' ' ASN . 31.3 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.81 34.76 25.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.556 ' H ' HG23 ' B' ' 90' ' ' VAL . 0.8 OUTLIER -114.68 177.55 4.6 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -165.65 94.54 0.6 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 111.319 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.76 137.21 49.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.2 124.76 26.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.183 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -122.62 113.47 19.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.633 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.367 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -150.99 167.97 26.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.399 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -160.93 41.19 0.16 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.48 178.75 9.57 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.71 99.94 0.15 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.689 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.33 163.86 15.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 111.091 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.5 135.79 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.07 143.38 29.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.058 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 147.82 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.995 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -89.35 126.33 35.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 82' ' ' VAL . 14.4 m -103.79 127.7 57.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.103 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.674 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 3.8 mp -103.15 110.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.67 133.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.52 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -110.12 124.42 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.41 143.02 58.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.49 -176.47 4.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.66 -34.25 69.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.786 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -97.13 13.41 29.32 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.611 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.63 -170.41 51.09 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.488 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 18.1 m-85 -71.09 -48.46 52.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.72 53.7 3.3 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.784 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.9 pp -149.95 138.48 20.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.864 0.364 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m -109.76 121.71 45.85 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 32' ' ' VAL . 31.0 m -120.13 157.62 22.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.407 ' OG ' HG22 ' B' ' 94' ' ' VAL . 34.2 t -139.2 162.55 34.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.622 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.82 -151.55 19.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.305 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.73 -89.31 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.998 0.399 . . . . 0.0 111.692 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -50.02 -61.79 3.29 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -93.34 64.49 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.983 2.455 . . . . 0.0 110.805 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 24' ' ' VAL . 21.3 t -47.72 117.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -99.8 124.45 45.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.692 HG22 HG12 ' A' ' 24' ' ' VAL . 21.6 t -85.62 124.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.058 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -71.7 0.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.221 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.1 m -99.84 139.86 34.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.792 HG12 HG23 ' A' ' 48' ' ' THR . 9.6 p -138.05 146.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.096 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA3' ' A' ' 39' ' ' GLY . 3.5 mttt -63.03 125.71 24.92 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.46 -25.92 38.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.576 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -129.27 54.52 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.003 0.43 . . . . 0.0 111.146 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 36' ' ' LYS . . . -150.94 -175.77 23.18 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.667 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.79 -36.84 39.04 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -54.41 -61.82 2.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.67 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.67 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -33.81 71.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.809 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -81.26 -15.03 56.73 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.53 25.92 6.1 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.948 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.03 136.5 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.757 0.279 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HA ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -131.25 159.01 39.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.233 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.792 HG23 HG12 ' A' ' 35' ' ' VAL . 11.8 p -64.44 115.03 4.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.58 78.11 1.31 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -142.52 145.29 33.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.038 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.76 137.51 35.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.609 ' HB ' ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -106.74 124.21 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.753 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' ' 83' ' ' GLN . 18.1 mt -103.91 -33.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.586 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HE2' HD23 ' A' ' 59' ' ' LEU . 12.8 mttt -148.19 158.17 43.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.381 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 80' ' ' LEU . 4.3 m -131.97 113.79 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 HG12 ' A' ' 78' ' ' VAL . 5.2 m-20 59.93 33.36 21.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.08 -39.5 3.1 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.492 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.64 119.69 9.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.689 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HE2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -64.02 140.98 58.93 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.599 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 53' ' ' ILE . 30.3 m -94.23 27.53 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.781 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -55.41 -38.47 68.98 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.157 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -144.59 31.5 1.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.362 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -82.92 117.59 22.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 m120 -68.47 172.18 6.45 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.337 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -56.9 -65.39 0.62 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.86 -33.81 51.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.181 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.79 -49.29 78.23 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG12 HD11 ' A' ' 72' ' ' ILE . 24.3 t -61.31 -52.72 58.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.569 HG22 HG21 ' B' ' 95' ' ' THR . 22.0 t -58.07 -47.67 86.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.75 -41.65 77.93 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.015 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -45.26 74.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.158 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 HG12 ' A' ' 68' ' ' VAL . 10.2 mt -66.15 -40.3 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.992 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' NZ ' HD11 ' B' ' 97' ' ' LEU . 0.1 OUTLIER -68.11 -33.21 74.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.932 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.3 p -77.93 67.58 3.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.327 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.85 144.36 3.9 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.54 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 p -72.91 -37.27 67.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.695 0.283 . . . . 0.0 110.981 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.62 139.1 51.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.22 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 72' ' ' ILE . 6.2 m -137.63 128.9 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.31 111.27 22.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -110.11 130.91 55.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.415 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 29.8 m -77.07 111.63 12.86 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.7 m -117.55 175.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 112.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 53' ' ' ILE . 12.0 tt0 -147.61 148.3 30.96 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.44 -142.26 7.06 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.732 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -100.36 158.0 32.76 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.559 0.219 . . . . 0.0 110.763 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.8 Cg_exo -56.68 139.07 87.45 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.638 2.225 . . . . 0.0 112.219 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 35.3 Cg_exo -62.25 -172.17 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.044 2.496 . . . . 0.0 112.791 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.64 -67.12 0.68 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.773 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.162 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.58 128.08 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.61 108.45 21.15 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.053 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.84 41.53 3.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.407 HG22 ' OG ' ' A' ' 25' ' ' SER . 25.0 t -102.6 137.94 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.961 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -122.87 150.43 42.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.029 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.77 122.21 20.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.45 HD11 ' NZ ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.28 134.48 38.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.991 0.424 . . . . 0.0 111.39 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -73.08 168.83 18.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.324 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.22 146.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.315 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.16 -77.29 2.14 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.839 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.55 157.16 37.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.8 125.1 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.486 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -102.92 142.8 33.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.752 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -144.73 149.47 35.63 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.536 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 p -102.68 124.75 48.79 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.27 128.31 65.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.048 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 4.1 mp -97.96 111.0 26.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.711 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 22' ' ' LEU . 28.0 mt -97.47 132.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.079 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 4.2 mt-30 -104.65 169.78 8.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.103 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 76' ' ' SER . 2.7 tmtt? -94.37 137.03 34.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.33 179.97 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.68 -33.51 70.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.14 13.71 33.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.651 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.48 -159.42 44.57 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.871 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.788 ' HB2' HD22 ' B' ' 97' ' ' LEU . 3.7 m-85 -66.16 -48.64 70.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.16 61.23 3.79 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.017 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.1 pp -149.9 148.04 28.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.481 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 m -113.2 122.05 46.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.95 151.32 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.895 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -139.3 132.09 29.13 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.562 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.74 176.33 23.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.99 -79.03 0.61 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 116.974 0.387 . . . . 0.0 111.299 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -49.81 -62.82 2.15 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 62.4 Cg_endo -96.37 66.93 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.382 2.722 . . . . 0.0 111.024 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.065 ' HB ' HG23 ' A' ' 52' ' ' ILE . 39.3 t -50.33 126.26 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.366 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.03 123.93 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 111.199 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.28 107.06 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.936 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.71 -65.04 0.74 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.167 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 48' ' ' THR . 88.1 p -143.69 158.62 43.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.79 0.328 . . . . 0.0 111.262 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 22' ' ' LEU . 15.9 m -137.75 152.7 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.325 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -57.45 135.98 56.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -73.88 -41.19 62.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.07 45.35 1.11 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.25 175.95 19.59 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.446 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.77 35.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 -62.05 1.93 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.538 0.209 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -67.91 -34.76 77.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.668 179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -34.75 75.05 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.696 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.16 -15.13 58.56 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.33 32.35 4.62 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.813 HG22 HG11 ' A' ' 11' ' ' VAL . 57.7 t -90.31 138.51 19.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.748 0.308 . . . . 0.0 110.705 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -108.0 167.58 9.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 34' ' ' SER . 5.7 m -86.73 105.15 16.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.78 56.69 0.5 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.694 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -110.66 163.06 14.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -120.04 84.48 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.773 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.065 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -71.47 129.48 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.219 0.533 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.7 mt -108.94 -35.79 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.581 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 27.3 mttp -128.82 148.54 50.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.553 0.216 . . . . 0.0 111.483 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 72' ' ' ILE . 4.5 m -127.11 104.62 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 111.352 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 78' ' ' VAL . 6.3 t30 59.39 37.07 23.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.906 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.37 -41.74 2.75 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.37 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.6 m -59.46 115.97 3.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.108 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.35 134.32 46.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.596 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 53' ' ' ILE . 9.6 p -94.95 32.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.349 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.612 HG23 HD21 ' A' ' 28' ' ' ASN . 55.8 m -93.23 -34.9 13.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -119.61 28.03 8.39 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.9 t -105.9 -178.83 3.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.5 m120 -119.37 165.4 14.36 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.067 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -57.49 -64.3 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.458 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.58 -42.93 98.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 64' ' ' ASN . 38.4 t -63.79 -52.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.228 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 73' ' ' LYS . 10.5 p -59.31 -40.89 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.379 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -42.83 99.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.56 0.219 . . . . 0.0 110.741 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -47.77 74.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 55' ' ' VAL . 41.6 mm -65.61 -42.05 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.917 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD2' HG22 ' A' ' 69' ' ' VAL . 37.3 mttm -67.48 -31.46 71.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.078 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -80.39 65.68 5.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.04 0.447 . . . . 0.0 110.729 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 172.02 31.51 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.435 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -91.05 -71.54 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 43.3 p90 -120.07 151.62 38.76 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.847 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 56' ' ' ASN . 5.1 m -149.47 147.54 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.778 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -99.41 111.23 23.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -106.25 128.9 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.97 0.414 . . . . 0.0 111.872 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 74.2 m -82.1 115.31 21.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.027 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.63 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.4 m -121.34 175.44 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.033 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.39 151.77 35.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.611 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.38 -155.26 7.42 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.834 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -141.23 103.78 6.08 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 152.39 77.81 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.79 137.39 67.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.751 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.36 40.45 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.382 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.0 159.61 25.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -101.74 173.98 6.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.61 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.12 77.84 1.81 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.148 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.03 137.17 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.947 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 157.07 44.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 110.882 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -151.59 155.57 38.7 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.739 0.304 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.299 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 120.264 -0.186 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t 56.92 78.19 0.23 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.983 0.42 . . . . 0.0 110.996 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 56.48 76.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.393 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.06 167.21 30.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.358 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.79 106.79 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.745 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.93 148.63 48.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.513 0.197 . . . . 0.0 111.122 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.38 126.01 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.273 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -99.23 147.73 24.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.308 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -149.76 154.3 38.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 5.8 t -92.18 119.06 31.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 82' ' ' VAL . 38.2 t -109.27 132.26 57.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.602 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.627 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 mp -95.14 110.78 24.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.574 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.628 HD12 HD22 ' A' ' 80' ' ' LEU . 30.5 mt -91.84 124.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.56 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 3.0 mt-30 -113.04 110.1 19.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.84 134.65 55.59 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.673 0.273 . . . . 0.0 110.982 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -176.78 3.05 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.16 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -60.14 -31.86 70.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.567 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -94.87 13.34 25.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.25 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.79 -155.21 30.21 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.733 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -85.35 -46.61 10.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.692 0.282 . . . . 0.0 110.585 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.97 51.33 14.93 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.991 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' A' ' 35' ' ' VAL . 3.9 pp -149.53 149.32 30.55 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.796 0.332 . . . . 0.0 111.207 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -108.15 135.82 48.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 32' ' ' VAL . 19.9 m -132.28 148.01 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.21 0.528 . . . . 0.0 112.103 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.67 162.45 33.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.572 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.49 -167.94 32.95 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.063 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.77 -82.73 0.37 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.11 0.455 . . . . 0.0 111.82 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.6 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -50.3 -61.92 3.23 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 64.5 Cg_endo -95.29 67.64 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.314 2.676 . . . . 0.0 110.769 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 22.4 t -48.42 114.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.455 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -99.35 123.63 43.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 24' ' ' VAL . 38.3 t -84.83 116.16 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.871 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -78.19 -66.71 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.122 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.87 147.97 45.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.752 0.31 . . . . 0.0 111.212 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 22' ' ' LEU . 2.5 m -137.52 151.77 26.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -67.03 95.65 0.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -32.36 47.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.385 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -113.46 36.49 3.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 -174.45 15.15 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -51.17 -38.35 51.64 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.79 -57.03 11.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.036 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -73.81 -38.28 64.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -34.6 70.42 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.656 0.265 . . . . 0.0 111.133 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -75.52 -15.05 60.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.6 15.51 16.87 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.078 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG12 HG11 ' A' ' 35' ' ' VAL . 16.7 t -95.0 121.17 45.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.946 0.373 . . . . 0.0 110.529 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -101.17 168.37 9.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.9 p -75.35 108.77 8.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.86 60.86 0.72 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.64 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -122.72 156.29 34.73 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.163 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 ttm-85 -107.53 140.44 40.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.98 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.954 HD11 HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -106.0 124.71 61.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 120.817 0.342 . . . . 0.0 111.024 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.529 ' O ' HG22 ' A' ' 60' ' ' VAL . 26.1 mm -102.92 -35.87 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -149.33 161.43 42.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 80' ' ' LEU . 30.7 m -133.94 116.17 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.39 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG12 ' A' ' 78' ' ' VAL . 1.4 t30 54.02 48.96 19.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.92 29.08 73.79 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.927 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -127.53 124.3 37.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.717 0.294 . . . . 0.0 110.532 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.77 123.2 18.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.835 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 53' ' ' ILE . 15.8 m -93.94 35.51 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 111.417 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 t -94.13 -27.17 16.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.178 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -121.1 46.58 2.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.028 0.442 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -127.22 149.26 50.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.657 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.1 m-20 -92.17 177.83 6.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -57.74 -66.39 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.021 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -57.39 -30.9 65.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -50.34 74.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.383 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.1 t -61.55 -52.99 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.474 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 66' ' ' LEU . 10.1 p -59.02 -40.42 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -40.89 98.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.553 0.216 . . . . 0.0 111.024 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -67.33 -47.81 69.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.001 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 80' ' ' LEU . 40.0 mm -66.57 -41.11 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.55 -29.65 69.09 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -76.42 67.98 2.7 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.019 0.438 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.75 148.5 4.77 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.124 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -68.33 -62.13 1.53 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.699 0.249 . . . . 0.0 110.882 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -119.22 149.61 41.47 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG12 ' ND2' ' A' ' 56' ' ' ASN . 3.1 m -150.18 147.94 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.56 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -94.49 111.09 22.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.535 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.954 HD23 HD11 ' A' ' 52' ' ' ILE . 8.0 mp -106.82 130.07 54.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.793 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 1.8 m -83.3 111.51 19.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.691 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 52' ' ' ILE . 3.6 m -116.64 175.37 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.068 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -149.09 149.54 31.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.29 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -170.05 -151.49 7.44 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.035 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 75.91 79.41 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 110.541 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.57 110.68 2.57 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.898 2.398 . . . . 0.0 112.548 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.23 162.59 41.76 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.758 2.306 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.3 95.2 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.648 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.925 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.498 0.189 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.07 31.38 4.44 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.062 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -126.23 128.81 47.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.855 0.36 . . . . 0.0 111.004 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 45.17 0.84 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 137.24 33.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.707 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.37 156.81 44.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.308 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.529 ' C ' HD23 ' B' ' 97' ' ' LEU . 0.6 OUTLIER -107.3 162.88 13.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.293 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.529 HD23 ' C ' ' B' ' 96' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.056 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 56.65 74.55 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.938 0.399 . . . . 0.0 111.372 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -133.8 121.81 22.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -109.25 33.38 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.16 -82.18 0.23 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.869 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.21 178.92 4.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.64 0.257 . . . . 0.0 110.991 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.09 139.32 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.249 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 83' ' ' GLN . 1.9 mt-30 -99.18 152.1 20.26 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -149.8 149.59 30.75 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m -108.41 137.1 46.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 46' ' ' VAL . 3.8 m -125.64 124.7 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.7 mp -95.24 110.48 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.112 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 80' ' ' LEU . 3.8 mp -98.41 132.76 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.124 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 1.8 pt20 -118.09 122.65 43.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.671 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.36 141.14 58.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 111.088 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.66 -171.92 3.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.823 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -34.6 69.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.121 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.91 -13.95 56.82 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.828 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.17 -173.51 39.39 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.767 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.08 -54.52 10.83 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.8 54.45 14.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.822 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.5 pp -149.77 140.87 23.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.625 HG23 ' HB3' ' B' ' 96' ' ' ASP . 66.9 m -124.65 124.68 42.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.28 141.81 35.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -129.73 161.23 31.14 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 30' ' ' VAL . . . 84.2 158.35 27.62 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.785 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -103.61 -173.94 2.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.72 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.703 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.0 m120 33.8 -93.36 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 O-C-N 123.773 0.67 . . . . 0.0 110.501 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.703 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 85.6 Cg_endo -77.52 60.43 7.1 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.614 1.543 . . . . 0.0 109.972 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' HG23 ' A' ' 52' ' ' ILE . 61.9 t -51.13 148.08 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.32 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -127.21 133.18 50.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 111.415 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.1 120.32 23.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.996 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -72.11 0.41 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 m -130.2 143.69 50.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.308 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 10.5 m -136.57 142.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.057 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -63.23 122.45 16.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.19 -40.44 94.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.29 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.91 41.29 1.31 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.72 -179.61 16.79 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.461 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.3 -34.36 46.41 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -54.7 -63.18 1.23 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.577 0.227 . . . . 0.0 110.92 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.38 75.83 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.837 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -58.52 -32.56 68.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.035 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 12' ' ' ILE . . . -84.33 -14.83 48.55 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.65 -15.52 17.02 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.045 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 11' ' ' VAL . 13.0 t -61.07 145.02 13.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.103 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -131.79 173.16 11.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.0 p -82.89 144.04 30.33 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.78 26.45 67.13 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.653 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.38 172.57 12.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.601 0.201 . . . . 0.0 110.618 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -122.11 80.62 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.933 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.948 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.4 116.18 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.392 0.615 . . . . 0.0 111.07 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -99.14 -39.81 8.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.677 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 2.7 mttp -139.45 168.12 20.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.702 0.287 . . . . 0.0 111.397 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.871 HG12 ' HG ' ' A' ' 80' ' ' LEU . 17.8 m -141.28 108.37 2.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 120.985 0.422 . . . . 0.0 111.175 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.13 34.08 21.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.78 3.12 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.139 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -67.64 97.26 0.6 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.582 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.746 HD12 ' OG1' ' A' ' 61' ' ' THR . 1.1 pt? -59.67 138.2 57.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.183 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.17 35.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.746 ' OG1' HD12 ' A' ' 59' ' ' LEU . 29.3 p -108.27 16.6 23.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.058 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.49 44.69 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.81 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -138.14 162.26 34.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.524 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.4 m-20 -84.96 164.92 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.457 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -60.17 -66.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -55.94 -30.72 62.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -47.19 85.09 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.441 0.162 . . . . 0.0 111.032 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' ASN . 36.2 t -62.74 -52.86 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.216 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 66' ' ' LEU . 12.8 p -60.31 -41.97 89.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.294 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.52 92.3 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.613 0.244 . . . . 0.0 110.775 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.2 -48.09 81.57 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.229 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -65.56 -43.2 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.588 0.232 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -68.04 -25.95 65.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.753 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m -56.34 -32.96 65.2 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.4 155.62 16.2 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -54.21 41.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.69 0.281 . . . . 0.0 110.765 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 53.4 p90 -118.09 143.0 46.82 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.549 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.33 148.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 80' ' ' LEU . . . -90.74 141.81 28.41 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.321 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.871 ' HG ' HG12 ' A' ' 55' ' ' VAL . 9.1 mp -125.54 115.22 19.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 0.0 111.141 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 6.6 m -86.16 101.07 12.67 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.516 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 52' ' ' ILE . 6.6 m -116.22 176.33 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.025 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' GLN . 12.8 tt0 -139.37 149.74 44.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.732 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.72 141.55 5.9 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.579 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -144.99 99.63 4.64 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.661 0.267 . . . . 0.0 111.095 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.59 159.79 22.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.774 2.316 . . . . 0.0 112.274 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.86 -177.13 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.054 2.503 . . . . 0.0 112.918 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.64 -43.54 0.35 Allowed Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.604 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.678 0.275 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -59.64 2.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -78.47 176.08 9.72 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.16 99.18 8.74 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.168 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.05 137.06 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -144.01 161.11 39.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.625 ' HB3' HG23 ' A' ' 23' ' ' THR . 1.2 p30 -152.16 161.11 43.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.912 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.019 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 108.15 18.42 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.714 0.293 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 175.25 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 59.93 37.83 21.31 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.95 68.48 3.49 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.374 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 6' ' ' LEU . 3.4 mm? -110.35 125.74 53.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.149 0.18 . . . . 0.0 110.669 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.3 134.78 65.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -103.55 151.53 22.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.437 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -149.38 148.2 29.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.29 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 97.0 m -90.31 123.96 34.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.914 HG11 HG22 ' A' ' 46' ' ' VAL . 21.4 t -109.75 119.56 59.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -97.62 116.68 40.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 80' ' ' LEU . 1.9 mp -114.77 129.44 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.65 128.21 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.686 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -61.95 127.8 33.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.55 -171.21 2.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -54.91 -35.11 63.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -97.39 12.28 33.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -166.32 43.18 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.738 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.37 -52.11 20.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.458 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.15 56.23 9.24 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.93 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HB3' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -149.43 137.08 20.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HA ' ' B' ' 96' ' ' ASP . 74.9 p -107.14 138.06 44.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 149.77 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.707 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -133.62 162.46 31.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.15 -165.33 37.62 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.769 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 30' ' ' VAL . 34.8 m-20 -137.75 -95.98 0.2 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.828 0.314 . . . . 0.0 111.332 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.4 m-20 -43.32 -63.78 0.92 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 60.2 Cg_endo -94.18 60.61 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.158 2.572 . . . . 0.0 110.01 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.653 HG23 HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.59 137.52 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 -178.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -126.1 129.58 49.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.067 0.46 . . . . 0.0 111.897 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 t -74.89 124.21 32.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.353 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -82.59 -66.54 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.264 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 48' ' ' THR . 1.4 t -131.38 150.27 52.22 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.334 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 22' ' ' LEU . 18.9 m -137.68 152.77 27.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.111 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -66.2 104.51 1.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.17 -31.53 67.34 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.88 42.8 1.95 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.05 16.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.65 -37.46 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.5 -60.27 3.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.671 0.272 . . . . 0.0 110.88 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -37.82 82.53 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.66 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -34.26 73.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.178 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.66 -14.9 59.93 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.44 27.9 5.64 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.864 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.914 HG22 HG11 ' A' ' 11' ' ' VAL . 25.6 t -95.2 147.97 5.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.727 0.263 . . . . 0.0 110.911 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -126.89 169.14 13.58 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 34' ' ' SER . 1.8 p -84.21 124.21 30.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.697 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.55 41.82 4.08 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.924 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.64 160.93 14.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.477 0.18 . . . . 0.0 110.542 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -116.07 79.16 1.27 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG23 HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -67.36 129.5 31.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.406 0.622 . . . . 0.0 111.243 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.42 -42.0 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.467 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.653 ' HE3' HG21 ' A' ' 81' ' ' THR . 4.5 mttt -122.41 149.44 43.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 111.582 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 52' ' ' ILE . 13.3 t -124.59 101.59 9.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.695 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 78' ' ' VAL . 2.4 t30 58.15 39.7 25.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.177 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -43.11 2.61 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.181 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -66.75 106.49 1.87 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 157.1 34.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 60' ' ' VAL . 10.2 t -94.18 34.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 111.137 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -80.63 -32.81 36.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.607 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.4 31.74 4.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.048 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -118.65 138.92 52.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.705 0.288 . . . . 0.0 111.683 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.9 m-20 -97.15 -179.91 4.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.424 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -55.53 -64.55 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.31 -32.96 67.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -48.73 80.51 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.092 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 64' ' ' ASN . 23.5 t -61.12 -49.01 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.116 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 HG21 ' B' ' 95' ' ' THR . 16.0 t -56.99 -49.68 78.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.95 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -41.57 87.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.158 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 71' ' ' LEU . 10.4 tt -66.26 -47.93 72.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.368 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' CD1' HG12 ' A' ' 68' ' ' VAL . 30.8 mt -66.27 -42.39 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.597 0.237 . . . . 0.0 110.836 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -68.02 -29.62 68.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.786 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.8 p -79.98 67.38 5.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 111.132 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.19 148.04 4.98 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.15 -56.3 13.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.728 0.264 . . . . 0.0 110.828 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 33.5 p90 -122.69 164.04 19.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 80' ' ' LEU . 7.3 p -156.1 140.3 8.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.83 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . . . -104.77 111.33 24.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 78' ' ' VAL . 3.4 mp -107.27 129.61 54.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.653 HG21 ' HE3' ' A' ' 54' ' ' LYS . 24.9 m -82.71 110.06 17.42 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.61 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 52' ' ' ILE . 4.3 m -117.51 175.59 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.1 0.476 . . . . 0.0 112.0 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -136.46 151.17 49.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.248 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.12 -143.49 3.87 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.807 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.65 101.14 3.73 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 111.164 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.78 170.1 14.74 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.98 132.16 38.2 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.601 2.201 . . . . 0.0 112.484 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.72 -38.79 30.88 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.667 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.535 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.446 0.165 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.8 87.68 7.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.96 135.71 54.46 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 79.82 1.34 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.029 0.443 . . . . 0.0 110.572 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.95 137.65 50.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.505 HG21 HG22 ' A' ' 69' ' ' VAL . 23.6 m -123.89 149.17 46.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.892 0.377 . . . . 0.0 111.154 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.9 m-20 -134.13 112.73 11.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.226 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.408 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.686 -0.165 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -73.15 -177.47 2.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -175.29 0.85 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.012 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.3 mtm -103.06 107.12 17.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.848 0.356 . . . . 0.0 111.572 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.51 -32.13 3.51 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.766 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.14 178.95 5.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.768 0.284 . . . . 0.0 111.053 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.98 123.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.967 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -99.19 147.0 25.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -148.61 143.48 26.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HG23 ' A' ' 81' ' ' THR . 80.5 m -107.73 138.35 44.11 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.87 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -131.87 130.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.191 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 3.9 mp -95.29 129.3 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.52 130.83 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' TYR . 3.1 tt0 -103.07 112.74 25.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -63.68 143.13 58.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.25 -174.2 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.98 -32.79 68.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.978 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.07 -14.17 56.23 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.662 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.56 -170.64 35.52 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.75 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.21 -52.66 7.11 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.7 0.285 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.3 57.63 2.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.872 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -149.95 145.13 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.933 0.396 . . . . 0.0 111.638 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -114.45 129.57 56.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.75 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.19 142.9 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.998 0.428 . . . . 0.0 111.385 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.9 m -139.62 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.51 169.38 45.9 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.901 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' ASN . 6.1 p-10 -106.02 -166.51 1.2 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 119.632 -0.223 . . . . 0.0 111.03 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-20 21.27 -85.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 O-C-N 124.064 0.853 . . . . 0.0 111.453 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 93.2 Cg_endo -78.76 57.81 6.56 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.78 1.653 . . . . 0.0 110.221 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.994 ' HB ' HG23 ' A' ' 52' ' ' ILE . 58.1 t -48.04 138.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.989 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -113.26 130.72 56.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.0 108.56 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.295 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' THR . 10.6 tt0 -61.6 -65.32 0.71 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.488 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 48' ' ' THR . 2.6 m -144.46 158.59 43.68 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 111.287 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 16.9 m -134.68 153.09 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 115.19 3.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -60.12 -28.67 68.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.409 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -132.01 57.21 1.79 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.453 . . . . 0.0 110.604 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.55 -168.09 13.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.13 -40.19 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.447 0.165 . . . . 0.0 111.395 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -56.33 -52.26 65.21 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.92 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -43.11 73.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -36.63 73.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.077 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.93 -14.73 60.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.995 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.96 38.21 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.222 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.87 HG22 HG21 ' A' ' 11' ' ' VAL . 14.9 t -70.27 147.96 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 111.485 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.82 164.2 27.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' SER . 85.7 m -65.69 137.79 57.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.982 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.21 55.66 2.72 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 172.34 7.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 84.39 2.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.691 0.282 . . . . 0.0 111.123 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' HB ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -69.14 120.41 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.223 0.535 . . . . 0.0 110.792 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 60' ' ' VAL . 39.9 mt -107.24 -33.49 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.588 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' CD ' HG21 ' A' ' 81' ' ' THR . 1.1 mtpt -138.39 164.12 30.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.724 0.297 . . . . 0.0 111.521 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 ' HG ' ' A' ' 80' ' ' LEU . 15.9 m -139.17 108.25 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.727 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER 61.08 32.02 19.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.246 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.61 -34.66 4.5 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.16 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m -72.84 111.5 8.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 150.4 48.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.076 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 28' ' ' ASN . 27.0 m -89.58 19.2 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.735 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 p -91.01 -36.89 13.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -89.25 -32.87 17.19 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.89 154.57 38.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 3.8 m-80 -94.28 -178.08 4.48 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' VAL . 13.8 t-80 -67.06 -61.0 2.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.97 -26.03 62.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.016 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 71' ' ' LEU . 4.6 tt0 -67.96 -50.66 54.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.246 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 72' ' ' ILE . 12.3 p -60.27 -44.73 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.748 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 73' ' ' LYS . 9.9 p -65.4 -44.21 94.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.373 0.13 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -41.56 96.6 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.769 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.4 mm? -65.68 -45.63 82.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.942 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.742 HG23 HG11 ' A' ' 78' ' ' VAL . 17.8 mt -66.74 -40.44 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.806 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 69' ' ' VAL . 3.0 mptp? -67.91 -31.18 70.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.261 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -81.99 66.49 7.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.41 160.06 21.87 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.568 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -53.75 10.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.5 0.191 . . . . 0.0 111.097 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 48.9 p90 -131.28 164.39 25.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 110.728 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG11 HG23 ' A' ' 72' ' ' ILE . 14.8 p -153.92 146.15 14.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 111.999 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -92.99 141.88 27.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.359 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.627 ' HG ' HG12 ' A' ' 55' ' ' VAL . 3.5 mp -126.64 115.34 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 111.333 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.494 HG23 ' SG ' ' A' ' 10' ' ' CYS . 32.9 m -91.69 102.36 14.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.532 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -116.33 176.03 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.04 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -139.01 148.14 43.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.014 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.57 -167.54 17.98 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.047 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 145.69 31.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 51.3 Cg_exo -51.59 -49.45 17.15 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.918 2.412 . . . . 0.0 113.12 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 72.4 Cg_endo -75.1 135.2 18.58 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -172.02 101.7 0.17 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.462 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.845 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.688 0.28 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.04 154.3 19.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.101 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.493 ' ND2' HG13 ' B' ' 94' ' ' VAL . 1.4 t30 -70.4 160.57 32.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.25 60.5 1.7 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.434 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.493 HG13 ' ND2' ' B' ' 92' ' ' ASN . 16.2 m -113.24 137.2 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.569 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 69' ' ' VAL . 35.1 m -147.0 150.76 35.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.53 139.88 52.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 110.865 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.533 HD21 HG21 ' A' ' 72' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.409 -179.714 . . . . . . . . 1 1 . 1 stop_ save_